key: cord-0041622-ao10ky45 authors: de Benito, Amparo; Ibáñez, Clara; Moncho, Walter; Martínez, David; Vettorazzi, Ariane; de Cerain, Adela López title: Database on the taxonomical characterisation and potential toxigenic capacities of microorganisms used for the industrial production of food enzymes and feed additives, which do not have a recommendation for Qualified Presumption of Safety date: 2017-08-03 journal: nan DOI: 10.2903/sp.efsa.2017.en-1274 sha: c8c0f1daa6e5a93c6d1677ea5c185190485f3eb1 doc_id: 41622 cord_uid: ao10ky45 nan The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The use of microorganisms in industrial fermentations for the production of food and feed additives (enzymes, vitamins, antimicrobial substances, etc.) with beneficial effects for agriculture, farming and primary food production is in continuous development. However, the production of secondary metabolites by these microorganisms should be studied and the safety of the products obtained during fermentation should be assessed properly before its commercialization. In order to define appropriate endpoints for the safety assessment of microbial fermentation products, it is necessary to identify the production microorganisms and the range of toxic compounds which can be produced by them. In addition, further information on the molecular and genetic basis of the production of such metabolites helps to evaluate and compare the efficiency of any genetic manipulation that could be designed and performed to avoid their synthesis. Thus, obtaining a database from a review on the appropriate taxonomical identifiers and potential toxigenic capacities of these microorganisms provides information that can be used to establish safety measures when using potentially toxigenic microorganisms in industrial fermentations. This report is the external scientific report of the European Food Safety Authority (EFSA) contract OC/EFSA/FEED/2015/01, and describes the methodology and results of a project aiming to provide EFSA with a database from a review on the correct taxonomical description and potential toxigenic capacities of microorganisms used for the industrial production of feed additives and food enzymes. Data collection is an important task of EFSA and a fundamental component of risk assessment (Articles 22 and 23 of Regulation (EC) No 178/2002) . The extraction of the scientific information was retrieved in a database, which structure of the data model and its terminology was established according to EFSA standard coding systems. The methodology applied in this project consisted in the following steps: systematic search by the application of a well-defined searching strategy, the study of the information obtained and extraction methods and the integration procedure to store the relevant information. The database contains detailed information on (1) taxonomical descriptions and potential toxigenic capacities of microorganisms used for the industrial production of feed additives and food enzymes; (2) the type of toxic compounds that can be produced; (3) the physiological conditions in which each identified toxic compound is produced; (4) the biosynthetic pathways and corresponding genes leading to the production of the toxic compound; and (5) the mechanism of toxic action of the identified toxic compound and the dose under which harmful effects are observed in humans and animals. The systematic search has been done with the aid of an ad hoc searching platform (iWatch) to perform automatic searching that supports the data searching, extraction and management of the workflow. This automatic searching tool was set up to access eight searching engines as well as 45 web sites and provides a way for organising the data in a temporary local database that could be then exported to be integrated in the final database. In total, 22970 scientific documents have been retrieved with the searching platform and manual search, classified by microorganism and reviewed, to obtain pertinent data. A total of 411 scientific documents were selected that contain data on 474 secondary metabolites with bioactivity. A selection 1. Introduction The aim of the contract was the preparation of a database from the results of a systematic search set to establish potential toxicological profile of microorganisms for which EFSA has received or can potentially receive applications for safety assessment, and which have not been recommended for Qualified Presumption of Safety (QPS) status, excluding the microorganisms for which EFSA has already established a guidance for the assessment of their potential toxicity. The prokaryotic and eukaryotic microorganisms that should be considered as minimum are alphabetically listed as follows: • Searching from a wide range of sources • The methodology applied is summarised in Figure 2 . As shown in Figure 2 , after defining search criteria according to the required information and validated by EFSA, the systematic data search (A) was performed by two ways, either by manual searching or by the automatic scanning tool of the iWatch platform (Web Crawler, marked with an asterisk), which was used in all the cases where structured data sources allowed data scrapping. The scanning tool was configured with the information sources (scientific searching engines as well as scientific web pages) that were accessible to the crawling tool designed as well as with the keywords defined in the searching strategy. This system allowed for rapid data collection from multiple sources and easy Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 10 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). access to the information. Searches in engines or other information sources which did not allow automatic crawling were done manually. To allow the management of all references (both automatic and manual searches) iWatch Platform provided a user interface as a collaborative environment for the users. On one side, the platform facilitated the integration of all results and their analysis after its configuration with the working methodology based on the inclusion/exclusion criteria. On the other side, the system permitted users to add information by filling formularies configured to include the required information for the data base. The searching strategy was defined after a preliminary study in which,general information about the fermentative process involving the microorganisms within the scope was obtained. This allowed to identify possible problems that can arise when retrieving data from this heterogeneous group of microorganisms, for instance, the large amount of literature associated to some of the microorganisms For the purpose of the present review, a specific search to obtain taxonomical data was performed in databases specific for taxonomy (see Section 2.2.3) by searching each of the names of the species considered in the scope of the review. The information obtained by this search provided data for the review objective 1. For the rest of the review objectives, the search was carried out using the different groups of keywords described above, that cover a range of searching terms in relation to toxins, additives, fermentative processes, biosynthetic pathways and toxicology. A combination of the name of the species and the different groups of keywords allowed to obtain several lists of documents that were further screened by applying the inclusion and exclusion criteria (Section 2.3). For the group Species I, the lists of documents were obtained by searching only the name of microorganism (List 1). For Species II, the List 2 was obtained by searching the name of the microorganism AND keywords group 1. For Species III, the List 3 was obtained by searching the microorganism name AND keywords group 1 AND keywords group 2. Once obtained these three lists, the inclusion/exclusion criteria defined for this first screening (see Table 2 in section 2.3.1) were applied to obtain the List 4. The documents from this List 4 give information of the toxins or potentially toxic compounds that can be produced by the microorganism. They could be directly included in the Lists 5, 6 or 7, depending on the type of information provided. The toxic compounds retrieved from these documents were used as keywords for three new searches:  List 5: toxic compounds combined with keywords group 3 (process conditions) and the name of the species. The documents resulting from this search were subjected to the corresponding inclusion/exclusion criteria ensuring that they cover conditions of production of the toxic substance when produced by the microorganisms within the scope of the project. This fed List 8 that went for data extraction.  List 6: toxic compounds combined with keywords group 4 (toxicology). The documents resulting from this search were subjected to the corresponding inclusion/exclusion criteria to feed List 9 that went for data extraction.  List 7: toxic compounds combined with keywords group 5 (biosynthetic pathways) and the name of the species. The documents resulting from this search were subjected to the corresponding inclusion/exclusion criteria ensuring that they covered genes and pathways for the production of the toxic substance by the microorganisms within the scope of the project. This fed List 10 that went for data extraction. The documents included in List 8, 9 and 10 were full-text screened for quality and adequacy before data extraction. The web crawler is integrated in an "ad hoc" platform called iWatch that allows the automatic search of scientific data on structured web sources by providing a tool for web scrapping (Web Crawler), parameterized with the search strategy explained in the previous section. For this purpose, the tool was configured in order to allow searching from the proposed databases and web sources (see Appendix B) applying a matching algorithm that filters and classifies the articles within the different lists. To this end, as required by the strategy, the algorithm checks title and abstract looking for any of the keywords depending on the microorganism type. For all the articles searched (which included at least one of the microorganisms or synonyms considered for this tender), the Web Crawler searched on title or abstract the required keywords depending on its group. The following figure displays the Web Crawler architecture where experts specified both the keywords and the search strategy: Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 14 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The result of the automatic search was stored in the iWatch database as a list of articles tagged by the microorganism and classified by the matched keywords, and was accessible using the iWatch user interface In order to avoid double counting of studies, the scientific documents were compared for title, author names and publication area in which the study was conducted. The duplicates were discarded. This was done automatically by iWatch. In addition to the review undertaken by the Web Crawler tool, a complementary manual literature search was carried out using the methodology explained above to search the sources that do not allow automatic searching The search was conducted through a comprehensive list of searching engines, scientific web pages and other sources containing technical data. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). For the rest of the review objectives, the The selection of the scientific documents recovered in the search was done following the criteria explained below. The relevant studies selected were: -referring to the microorganism of interest as a producer of a secondary metabolite/toxic compound -providing data on its taxonomical identifiers and potential toxigenic capacities. Studies providing data on toxicity of compounds that have already been assessed by EFSA have been included in the database but extraction of data from the toxicological point of view has been considered not necessary. The selection and extraction process has been conducted in two stages: Level 1 and Level 2. Level 1: Screening of titles and abstracts: Inclusion/exclusion criteria were applied after reading either in the title or abstract of the documents retrieved at each stage of the searching (List 1-List 3 and List 5-List 7). Examination of title and abstracts of documents included in list 4 permitted the identification of the secondary metabolites produced by the microorganisms that might have a potential toxic effect. Some documents from List 4 were also included directly in Lists 5, 6 or 7, depending on the type of information provided. After having identified the potentially toxic metabolites from List 4, a second search was carried out with the corresponding keywords (see Figure 3 ), to obtain documents for Lists 5, 6 and 7. The title and abstract of these documents were read and the corresponding inclusion/exclusion criteria (see Table 2 ) applied to select the documents for Lists 8, 9 and 10, respectively. The full text of reports from Lists 8, 9 and 10 were examined at Level 2. Inclusion/exclusion criteria (see Table 3 ) were also applied at this stage, in order to select the documents that met all the conditions to extract the information for the database. The examination of the complete documents allowed in many cases to discard documents that passed the screening at Level 1, but that after a further examination were concluded as not containing relevant data. Documents containing any relevant information to provide data for the review objectives were used to extract information for the database. The quality of the information was assessed by the application of the inclusion/exclusion criteria. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). For both levels, the lists of documents were evaluated by two independent reviewers (parallel review) from each area of specialization (microbiology, molecular biology and toxicology). In the case of disagreements between them, the scientific document was discussed to reach a consensus before proceeding to the next step of the screening process. Screening of titles and abstracts for the relevance of the study questions: Level 1 The inclusion/exclusion criteria used to select relevant documents at title and abstract level are described in the following table (Table 2) . 1 List of food enzymes & feed additives provided in Appendix D is used as exclusion criteria. If the substance regarded as toxic is included in the list, the document is considered ineligible, because the scope of the review does not include an assessment of the toxicological aspects of the food enzyme or additive itself but other not intentionally produced substances that could occur during the fermentation. The screening consisted of several steps corresponding to four lists of questions (Table 2 ). It is defined that if any inclusion criteria was not fulfilled (answered NO) it was not necessary to proceed with the screening and the document was considered ineligible (all inclusion criteria must be answered YES or UNKNOWN to be included in study). On the other hand, if any exclusion criteria was answered YES the document was also discarded (exclusion criteria must be answered NO or UNKNOWN to be included in the study). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). In the majority of the cases, the screening did not identify precise information concerning specific eligibility criteria regarding the toxicity of the compound; therefore the answer was inconclusive (UNKNOWN) that led to the inclusion of the document. The document was selected and the secondary compounds mentioned in these scientific documents recorded in a form "ITEM ENTRY" (see Section 2.4.) . From all the compounds initially recorded, the ones selected for the second search had to comply with at least one of these conditions: 1) The compound is referred as a toxin in the scientific document or is a known toxin or mycotoxin or is involved in the biosynthetic route of one toxin. 2) The compound has been found to be produced by more than one species. 3) More than one reference has been found indicating the production of the compound by one species. Documents that potentially met eligibility criteria at the abstract and title screening stage were retrieved (Lists 8-10) and the full text documents were reviewed for eligibility. The criteria for inclusion or rejection of full text documents are recorded in the following table (Table 3) . The reasons for rejection of full text articles are justified and recorded in Appendix F of the report, together with their references. Compounds of potential concern but with no standard toxicity information to be included in the final database (e.g. a very preliminary toxicity assessment, study of interaction with a molecular target, etc) are reported in Appendix G. They were found at the first level of the reviewing process, to obtain the name of the secondary metabolites potentially toxic that might be produced by the different species. They were identified whether in the abstract or when reviewing the complete document at level 2. consensus. In every case possible the extraction of the data was aided by the collaboration platform iWatch as explained below. The interface provided by the iWatch Web platform eases the work of filtering, reviewing and extracting the data required by the tender as specified in the methodology. The platform provides the functionality required to manage the outcomes of the search strategy, allowing for the storage of the manual search results and the management of the automatic search results. Regarding the collaboration tasks, the tool has allowed the following functionalities:  Filtering of documents by the keywords groups used in the searching strategy, allowing for the distribution of the work within the experts groups.  Creation of classifying folders in order to facilitate the reviewing cycle (experts should be able to review documents two times).  Executing batch actions with a group of entries to allow selecting a group of entries and executing the same action with all of them.  Searching documents by words within a defined list to facilitate the application of inclusion/exclusion criteria (batch actions allow removing or adding tags to identify them).  Addition of tags to identify documents within a topic.  Discard non useful documents or addition of documents found by manual search.  Inclusion of comments into each entry to save important information found. Also, iWatch tool was configured to facilitate the work of data extraction by allowing entering data through different forms. These forms were designed after the information required for the data model which included text and numerical fields and drop-down lists when required to select options for EFSA collections. Finally, the submissions sent by the users were also stored at the platform database. The following forms for data registration were created:  Item Entry: internal entry form that allows introducing and collecting possible toxic compounds of interest extracted from List 4. It includes information about the source, the microorganism and toxic compound. This information was used to obtain Appendix G.  Fact Entry: entry form to include information extracted from selected articles of interest from Lists 8, 9 and 10, which will be included into the database. It includes information about the source, the microorganism, biosynthetic pathways, process conditions and toxicology. To extract the data submitted by users, iWatch export module was configured in order to allow the processing of all entries and its storage in a Data Schema created for this project as defined in section 2.6. For each entry, the module processes all fields converting to the format required for the data base specifications when required (see Appendix H) and stores the result in the schema. Once stored, the Data Base Management System allowed the data extraction in the XLM format required by EFSA. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 20 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The overall development of this review was carried out under a framework of quality assurance system and under the supervision of a Quality Assurance Unit. The main feature to control the quality of the review and the data extracted was a double check review done by two experts for each area of knowledge (microbiology, molecular biology and toxicology). Moreover, and specifically for this project, a number of control mechanisms at the data entry level were implemented to guarantee high quality of deliverables and reduce unintended errors:  Sharing the preliminary results with the requestor in order to obtain an external validation of the work that has already been done.  Expert groups meetings to review the methodologies and conclusions.  Furthermore, an external quality check was implemented by: -Automatic verification of data quality at the data entry level. -Manual revision of the collected data to be submitted. Automatic verification entails the definition and implementation of rules aiming to minimise errors during data entry, thus maximizing data quality. In the data entry phase, errors that can be detected automatically are: type mismatches, missing values for mandatory fields, wrong format (e.g., dates), and length exceeding the maximum allowed size. For these structural errors the nature itself of a Database Management System (DBMS) engine such as MySQL can prevent to store wrong data. In fact, at the database creation phase, it was specified for each fields its type, length, and format and if it is a mandatory field. In this way the DBMS will not allow storage of data that is not compliant with the corresponding field definition. In addition, more complex rules can be specified to the database engine using the SQL language, such as foreign keys. For catalogue fields, namely fields that can assume only a value chosen within a predefined list, it is possible to define catalogue tables and refer to them in the proper fields through the creation of foreign keys. A web-interface guides and supports the operator in the data entry phase. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 21 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). A relational database (Appendix H) was designed to store the extracted information, following a relational methodology based in an iterative process, in which EFSA provided a framework and advice for the database structure. The starting point for this database is the harmful substance or toxin produced by the microorganism as a secondary metabolite during the fermentative process. This substance is always going to be associated to the PARAM substance definition as provided in the standard sample description (EFSA, 2013). If a substance was not included in the EFSA PARAM catalogue, such substance was intriduced as explained previously. The information to be provided to the EFSA DCF Data Manager for these substances is included in Appendix I and contains the following: The Chemical Abstract Service registration number of the substance. The CAS number can be retrieved from publicly available databases such as: PubChem, ChemIDPlus, etc. The molecular formula is reported. The molecular formula can be retrieved from publicly available databases in particular PubChem (Bolton, 2008). The SMILES (Simplified Molecular Input Line Entry Specification) for the substance. The coded structure can be retrieved from publicly available databases such as: PubChem, ChemIDPlus. The structure code can be also obtained by manually drawing the structure in popular chemical drawing programs that allow for the SMILES generation such as ChemSpider. When this option is used, verification of the structures codified will be done. Together with the SMILES, the source of this notation will be also included. Figure 6 shows the logical map that represents the intrinsic properties of the data to be structured in the database as extracted from this scientific review and describes the following tables of keywords: Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 22 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Descriptors of the metabolic route used by the microorganism for the synthesis of the toxic compounds associated to the facts. Descriptors of the processing conditions in which the microorganism is able to synthesize the toxic compounds associated to the facts. Descriptors of the toxicological parameters of the toxic compounds associated to the facts. Descriptors of the document from which the information for the facts is obtained. The descriptors chosen for each of the features (tables) forming the data model were the following (see also Appendix H; Excel file of the Data Model):  id_ProcessToxins: Unique ID for fact_processtoxin table.  id_op (FK): Foreign key (FK) with a unique ID from the source table.  id_microorganism (FK): Foreign key with a unique ID from the microorganism table.  id_tox (FK): Foreign key with the unique ID from the toxicology data. Foreign key with a the unique ID from the process conditions table.  id_biosynthetic path (FK): Foreign key with a the unique ID from the biosynthetic pathway table.  id_microorganism (PK): Primary key (PK) with a unique ID for the microorganism table.  TAXONOMY_METHOD: Acceptable scientific methodologies and techniques for the identification of microorganisms. This data type is a code from the ANLYMD catalogue.  id_toxicity: This field refers to classification of critical effect according to toxicity target (Owens 2002) and the data type is a code from the TOXICITY catalogue.  Effect_desc: (Free text) Description of the effects observed in the toxicological study.  id_basis: Characterisation of the measures toxicological outcome measure. Its data type is a code from the BASIC_EFFECT catalogue.  Remarks: Additional remarks on toxicological study GENE  id_gene: The data elements belonging to this section describe information related to the gene.  Gene_name: Gene name involved in the synthesis of the substance.  Protein_name: Name of protein synthesised from the gene.  Gene_decription: (Free text) Description of the gene function.  Gene_sequence: Sequence of the involved in the synthesis route.  id_bio_pathway: The data elements belonging to this section describe information related to the identification of the biosynthetic pathway.  id_gene: The data elements belonging to this section describe information related to the genes involved in the biosynthesis of the compound.  id_microorg: The data elements belonging to this section describe information related to the taxonomy of the microorganism.  id_gene: The data elements belonging to this section describe information related to the genes involved in the microorganism identification.  housekeeping_gene_GenBank: GenBank ID for the housekeeping gene 3. Results A literature search was carried out for each microorganism included in the scope of the project with the purpose of assessing the available scientific information on the taxonomical characterisation (see section 2.2.3.). A list of microorganisms including information about its valid current name and the taxonomic ranks (kingdom, order, family), as well as other scientific names and synonyms, was prepared and sent to EFSA for the inclusion in the MTX catalogue. The literature search on taxonomy data produced 123 references with the methods for its relevant and accurate taxonomical identifiers, genomes sequenced and housekeeping genes (see Appendix J, and Appendix K). Bacterial taxonomy determination is mainly based on several molecular techniques, each one for retrieving the information at different levels (proteins, fatty acids, DNA) and the obtained results are combined and analysed to reach the correct taxonomic identification of the microorganism. The taxonomy of fungi is currently very complex. There is still an ongoing need of unique identifiers harmonisation, in this regards, big data tools contribute to harmonise approaches (three official The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). registries are approved: MycoBank, Index Fungorum, Fungal Names). However, debate on species concepts in the mycological society results in a lack of a universally accepted fungal taxonomy. Several studies have been dedicated to explore high-throughput expression profiles, in order to identify candidate housekeeping genes. The 16S ribosomal RNA (16S rRNA) gene sequence to study bacterial phylogeny and taxonomy has been universally accepted as the common housekeeping genetic marker. A commonly used reference gene for fungi is the 18S ribosomal RNA (18S rRNA). The accession numbers to the Genbank database for the sequences of the conserved genes found in the search is reported in Appendix J (Appendix J Bacteria, Appendix J Fungi). The appendix also includes the links to the available ID genome annotations for the type species of the microorganism when available. Those links allow downloading sequence and annotations for current versions of genome assemblies from the NCBI genomes FTP site. The results of the taxonomic review were integrated into the database, and synonyms were also included as new keywords for the searching strategy. According to the searching strategy explained in Section 2.2, IWatch tool was set up and configured for the retrieval of scientific documents that match with the different sets of keywords and nonsearchable databases were manually searched in order to complement the search. The total number of scientific documents retrieved for the first level was 22970. The references were distributed into several groups using the microorganism name as a keyword. The election of the articles for the revision by the two reviewers was also done by the IWatch tool that displayed the abstract and allowed direct access to the URL of the document. The reviewers labeled the articles as "first" or "second" revision and as "included" or "excluded" which facilitated the management of the review. After having examined the titles and abstracts of Lists 1, 2 and 3 (22970 documents in total) and applying the inclusion/exclusion criteria, 411 documents (List 4) were selected. The revision of the articles allowed the identification of 474 bioactive secondary metabolites synthesised by the different microorganisms of the scope that were subjectd to a further selection according to the criteria explained in section 2.3.1. Figure 7 shows the outcome of each searching and screening stage conducted in this project. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 28 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). For the second search, aimed to obtain pertinent information about the toxicity characteristics of the compounds, biosynthetic pathways and fermentation conditions, 59 compounds (see below) were selected from the total number of bioactive metabolites identified, based on the data available about the toxicity or potential toxicity of these compounds or the role they may have on the biosynthetic routes, as explained in section 2. In the second search to obtain List 5 and List 7, each of the 59 compounds were used as keywords, combined with the name of the microorganism(s) that produced the compound and the keywords Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 29 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). groups 3 and 5 to obtain the List 5 and List 7. List 6 was obtained for the compounds not included in Appendix E, as mentioned in Section 2.2. Additional information regarding the molecular characterisation of these compounds (Molecular formula, CAS number, SMILES, INCHI and IUPAC) was also obtained for those compounds not included in the EFSA catalogues (Appendix I). The URL with the toxicological information retrieved for each compound (as explained in section 2.2.3) was provided as supplementary data (Appendix C) 1 . In this review, it has been found that many of the species of microorganisms studied produce a wide range of secondary metabolites, in addition to the substances that are intentionally produced for industrial purposes. Several of these secondary metabolites have been described as toxic to humans and animals. In many cases, the metabolic role of these compounds is unknown and/or not well defined; however, biotechnological of biopharmaceutical interest in these compounds is considerable, as many of these substances have been studied for application in medical, industrial and/or agricultural areas. The benefits of these compounds as natural sources for pesticides, pigments, plant growth regulators, biocontrol agents, antitumor or antimicrobial products are in continuous research. There are still not enough concluding data about the possible adverse effects that these compounds could pose to mammals or humans, when unintentionally exposed to them through the diet or the environment. However, the unintentional presence of these substances in feed or food a contaminants from the fermentation product could raise safety concerns. The absence of toxicological information does not mean absence of toxicity, and thus more research will be needed for the toxicological characterization of these compounds. On the other hand, some of the substances found to be produced by fungi such as Aspergillus niger, A oryzae or Fusarium venenatum are well recognised mycotoxins, some of them already present in the current legislative frameworks. In these cases it is essential to obtain data about the genes involved in the biosynthetic pathways of these substances, as well as the culture conditions in which they are produced, in order to select the adequate strain and fermentation conditions that impair the production of these toxins. In this sense, it is common that industrial strains are genetically modified to avoid the expression of the genes responsible for the biosynthesis of mycotoxins. A list of the 474 bioactive secondary metabolites produced by the microorganisms within the scope of this project that have been found during the literature search is presented in Appendix G. The 59 compounds selected for further searching are marked in bold. In the present review, several mycotoxins and other toxic compounds have been found associated to the fungal species within the scope of this work. The most important and relevant facts in relation to the production of these substances are described below. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). fwe information about their biosynthesis, production and toxicological data on humans and animals is available. Some characteristics of these compounds are summarised below: 3-nitropropionic acid is a mycotoxin that inactivates succinate dehydrogenase thus inhibiting mitocondrial respiration. It is a neurotoxin that induces rat striatal degeneration; systemic intoxication by 3-nitropropionic acid induces selective lesions of the striatum in most species. It can be used as an experimental pharmacological model of Huntington disease in rodents. Thus, many articles related to the mechanism of action underlying striatal lesions have been found. In this project, 3-nitropropionic acid has been identified as a secondary metabolite of A. oryzae. Acute and subacute effects (5-days) were investigated in adult male Wistar rats after receiving 3nitropropionic acid doses by i. p. route (Szabó et al., 2005) . Several neurological alterations and a significant decrease of the thymus weight were observed in the treated rats. In another study, 3-nitropropionic acid was given by i.p. route to C57Bl/6 adult male mice in two different dose regimes: a low-dose (total dose of 340 mg/kg in 7 days) or a high-dose (total dose of 560 mg/kg in 7 days) (Fernagut et al., 2002) . The main objective of the study was to carefully characterise the motor disorder, its time course and the histopathological correlations. The low-dose regimen was not lethal but the high-dose regimen produced 37.5% of lethality to mice. The effects of 3-nitropropionic acid were evaluated in males of four different mouse strains: BALB/c, C57BL/6, FVB/n and 129SVEMS mice (Gabrielson et al., 2001) . It was found that 3-nitropropionic acid induced brain and heart lesions and that cardiac pathology had a different degree depending on the strains; the follow up investigation on the biochemical mechanisms of cardiac toxicity suggested that the inhibition of the succinate dehydrogenase in heart mitochondria was also the cause. Finally, acute intoxication of male and female adult Wistar rats was induced by the subcutaneous injection of 3-nitropropionic acid (20 mg/kg) once a day for 2 or 3 days (Nishino et al., 1997). Intoxication produced motor symptoms and striatum-specific lesions; it also irreversibly increased astrocytic [Ca2+]i. The possible mechanisms conducting to astrocyte destruction are discussed in the article. Andrastin A is a farnesyltransferase inhibitor isolate from Penicillium species including P. roqueforti . Andrastin A inhibits the activity of the ras protein farnesyltransferase, and therefore these meroterpenoids are promising leads for anticancer drugs, since the farnesylation of the ras oncogene protein is essential for its function (Uchida et al., 1996) . The first identification of the biosynthetic gene cluster for andrastins is based on genome database of P. chrysogenum. The cluster contains eleven genes, and nine of them are likely to be directly involved in the biosynthesis of andrastin A, the most complex andrastin molecule (Uchida et al., 1996) . The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Aristolochene is a sesquiterpene biosynthesized from farnesyl pyrophosphate by aristolochene synthase and is the precursor of a range of sesquiterpenoid toxins produced by filamentous fungi The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Asperparalines A, B and C, were isolated from okara (the insoluble residue of whole soybean) that had been fermented with A. japonicus JV-23, and they were shown to have paralytic activities in silk worms (Hayashi et al., 1997 and . More recently, it has been demonstrated that asperparaline A selectively blocks insect nicotinic acetylcholine receptors (Hirata et al., 2011) . No standard toxicity studies have been found in this review. Citreoviridin A is a mycotoxin found in cereal and bread grains. It exhibits pro-oxidative, anticancer chemotherapeutic, antibacterial, antifungal, and antiviral activities. In vitro, citreoviridin A increases ROS levels and decreases glutathione, inducing oxidative stress, destabilizing the lysosome and mitochondria and causing DNA damage. It is a neurotoxin, acutely toxic to mice, with intraperitoneal and oral LD 50 of 7.5 mg/kg and 20 mg/kg respectively (Ueno and Ueno, 1972). www.efsa.europa.eu/publications 33 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The sesquiterpene culmorin was first isolated by Ashleyet al. (1937) from Fusarium culmorum. It has been shown to be produced also by F. venenatum ( Cyclopiazonic acid (CPA) is a mycotoxin produced by the genera Aspergillus and Penicillium whic has been shown to be toxic in several animal species including swine, chickens, turkeys, guinea pigs, rats, and dogs. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Cyclopiazonic acid is an indole-tetramic acid mycotoxin and it has been reported to be produced by A. oryzae and P. camembertii, both species used in food fermentation ( The toxicity of CPA is attributed to its ability to alter normal intracellular calcium flux through the specific inhibition of sarcoplasmic or endoplasmic reticulum calcium-dependent ATPase (SERCA) essential for calcium uptake as in the muscle contraction-relaxation cycle, which results in increased muscle contraction. Regarding the biosynthesis, it has been reported that the gen cluster involved in CPA biosynthesis is adjacent to the aflatoxin gene cluster ) and that the dimethylallyl-cycloacetoacetyl-L-tryptophan synthase (DCAT-S) gene from an A. oryzae is involved in the CPA production, as disruption of this gene resulted in the loss of production of this toxin. These authors reported that the co-localization of the two gene clusters explains why strains of A. flavus and A. oryzae have different abilities to produce aflatoxin and CPA. This understanding has significant health implications. The genetic diversity of A. flavus and A. oryzae in the region adjoining the CPA gene cluster suggests a divergence of A. flavus from A. oryzae. The conclusion is that A. oryzae most likely descended from an ancestor that was the precursor of the Aspergillus SBG variant, while A. flavus descended from a precursor of A. parasiticus ). Regarding A. niger, it has been reported that it can be modified by mutagenesis, resulting in the deletion of gene clusters required for the synthesis of this mycotoxin (EFSA Journal 2014b). These compounds belong to the class of organic compounds known as trichothecenes. These are sesquiterpene mycotoxins structurally characterized by the presence of an epoxide ring and a benzopyran derivative with a variant number of hydroxyl, acetyl, or other substituents. The most important structural features causing the biological activities of trichothecenes are the 12,13-epoxy ring, the presence of hydroxyl or acetyl groups at appropriate positions on the trichothecene nucleus and the structure and position of the side-chain. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 35 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Kojic acid is produced by several Aspergillus and Penicillium species. It is a tyrosinase inhibitor thus inhibiting the production of pigments in animals and vegetables. Among other applications, it is used as a food additive to avoid browning of vegetables and crustaceans, and as a cosmetic ingredient for skin lightening. It was evaluated by the IARC and classified in the Group 3 not classifiable as to its carcinogenicity to humans, due to inadequate evidence in humans and limited evidence in experimental animals (IARC, 2001) . In this project, kojic acid has been identified as a secondary metabolite of A. oryzae (Chaves et al., 2012 ) and three reports giving information on toxic effects of this compound have been retrieved. In a 55-week chronic toxicity study performed on male F344/DuCrj rats, kojic acid was given at 0 (control group), 0.5% and 2% in the diet (Ota et al., 2009 ). Dose-dependent toxic effects were observed in liver, kidney, thyroids and adrenals, with very significant differences at the highest dose. A no observed adverse effect level (NOAEL) below 0.5%, which is equivalent to 227 mg/kg body weight/day in male rats, was determined. In a 26-week chronic toxicity study performed on male heterozygous p53-deficient CBA [p53(+/-)] mice and wild-type [p53(+/+)] mice, kojic acid was given at 0 (control group), 1,5% and 3% in the diet, and the tumorigenic potential in the thyroids and the liver was determined (Takizawa et al., 2003) . It was observed that kojic acid induced diffuse hypertrophy and hyperplasia of thyroid follicular epithelial cells with decreased serum thyroxine levels in both p53 (+/-) and p53 (+/+) mice, but caused no thyroid tumors. In the liver, the incidence of altered hepatocellular foci and hepatocellular adenomas was significantly increased, and the heterozygous p53 (+/-) mice appeared to be more susceptible in terms of the tumorigenic dose of kojic acid, with a greater prevalence of hepatic proliferative lesions. Thus, the contribution of genotoxicity on hepatocellular tumor development could not be ruled out. Finally, a thorough investigation, under Good Laboratory Practice (GLP) conditions, of the genotoxicity and general toxicity of kojic acid, has been performed in order to estimate a margin of safety for topical exposure in humans to this compound (Nohynek et al., 2004) . The authors concluded that the genotoxic risk for humans using kojic acid as a skin lightening agent is negligible, and is in any case much less than from exposure to kojic acid from fermented foods. They also pointed out that the data obtained also suggested that consumer exposure from fermented foods does not pose a significant risk to human health. www.efsa.europa.eu/publications 36 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Malformins are a group of secondary metabolites originally discovered and isolated from culture filtrate of the fungus A. niger (Blumenthal, 2004) . No standard toxicity studies have been found in this review. The only in vivo study in which some toxicological endpoints were evaluated in BDF1 mice concluded that malformin C has potent cell growth inhibition activity, but the therapeutic index is too low to be an anti-cancer drug. Some of the compiled articles evaluated malformins for their potential therapeutic properties (anticancer, fibrinolytic, anti-HIV and antimicrobial activities). Three different types of malformins (A, C and E) have been studied. An LD 50 (3.1 mg/kg, i.p, mouse) (from 1975) has been found in ChemIDplus database. This compound was first isolated from the culture broth of a strain of A. oryzae (Blumenthal, 2004) . No standard toxicity studies have been found in this review. The only original document reporting toxic effects found is a study from 1962 (Iizuka et al., 1962 ). An LD 50 (> 3mg/kg, i.p, mouse) (from 1969) has been found in ChemIDplus database. Mycophenolic acid (MPA) is a toxic metabolite produced by many Penicillium species such as P. stoloniferum, P. viridicatum, P. brevicompactum, P. carneum, P. raciborskii and some strains of P. roqueforti. Mycophenolic acid (MPA) is an approved therapeutic drug used as an immunosuppressant and numerous articles devoted to its therapeutic effects have been found. Its main mechanism of action is related to a reversible inhibition of inosine monophosphate dehydrogenase. More toxicological data can be obtained from its preclinical and clinical assessment, mainly from mycophenolate mofetil, which is its prodrug. In this review, it has been found two reports on developmental defects in zebrafish embryos have been retrieved. Morphological defects including tail curvature and severe pericardial edema in zebrafish embryos were found in a dose-dependent manner (3.7-11.1 µmol/L). The teratogenic index (25% lethal concentration value (LC25)/no observed adverse effect level ratio) was 16, which Other report with preliminary toxicity assessments, such as cytotoxicity in zebrafish, mechanistic information related to damage of insulin-secreting cells of MPA or gastrointestinal tract toxic effects in rats have been found. A recent review providing an update of the literature on the pharmacology and toxicology of the prodrug of MPA, mycophenolate, in organ transplant recipients has been found (Staatz and Tett, 2014). Some information (updated in 1995) related to its genotoxic effects can be found in CCRIS and GENE-TOX databases (see Appendix C) . The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Various LD 50 (all previous to 1983) in different animal species and with different routes of exposures are collected in ChemIDplus database (see Appendix C) . In this review, reports have been found on the production of MPA in blue-veined cheeses due to the fact that P. roqueforti (a producer of MPA) is used in the production of this type of cheeses (Malekinejad et al., 2015) . These compounds have been associated with A. niger and are defined as a group of aromatic compounds able to cause central nervous system signs in albino mice and rats leading to death when dosed intaperitonially (Blumenthal, 2004) . No standard toxicity studies have been found in this review. It is a generic name of naturally-occurring structurally-related compounds. This compound has been described as an alkaloid produced by A. japonicus (Hirano et al., 1969) . No standard toxicity studies have been found in this review. An LD 50 (> 200 mg/kg, i.p, mouse) (from 1979) has been found in ChemIDplus database. Neoxaline has been reported to have antiproliferative activity (in an MTT assay) and arrest the cell The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Nigerazines were first isolated by Iwamoto et al. (1983, 1985 ) from A. niger and found to inhibit root growth of lettuce seedlings. Nigerazines can be extracted from the mycelia of A. niger (Iwamoto et al., 1983) . Acute toxicity (LD LO ) in mice was determined to be 75 ~ 150 mg/kg. This toxin was obtained in 1969 by Caesar et al. as a fungal alkaloid from the A. niger group. It can be extracted from culture filtrate and was demonstrated to be toxic to silkworm larvae (Isogai et al., 1975) . The compound was also found to be produced by A. phoenicis which is a species of Aspergilli Section Nigri (Cole and Cox, 1981). This compound has been identified as a secondary metabolite produced by A. niger together with other toxins, such as fumonisin B 2 (Sørensen et al., 2009) . No standard toxicity studies have been found in this review, an LD 50 (> 125 mg/kg, oral, chicken) (from 1979) has been found in ChemIDplus database. Oxalic acid is a toxic organic compound found in certain plants and natural sources. Although there have been reports of oxalic acid poisoning involving the consumption of food, toxicological effects in humans are relatively uncommon but include gastrointestinal effects, hypocalcemia secondary to calcium oxalate crystal formation and renal toxicity. A. niger is associated with pulmonary oxalosis consisting of calcium oxalate crystals, which generate local oxidants that cause cell injury (Blumenthal, 2004) . In this review, no standard toxicity studies have been found. Some information related to its genotoxic effects can be found in CCRIS (updated for this compound in 2006 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). WP2 UVRA/PKM101). A previous study from 1983 cited by the National Toxicology Program (NTP) also reported negative results for the Ames test. Another study from the NTP (1985) in which the effects of oxalic acid on reproduction and fertility were assessed in CD-1 mice via drinking water concluded that oxalic acid is a reproductive toxicant in Swiss mice at concentrations that reduce parental water consumption, but that cause few other somatic effects. Various LD 50 (previous to 1990) in different animal species and with different routes of exposures are collected in ChemIDplus database (see Appendix C). The LD 50 ranged from 112 mg/kg in cats (subcutaneous administration) to 7500 mg/kg in rats (oral administration). In humans, a lethal dose of 600 mg/kg was reported in 1980 (females). Several occupational limit values have been established by different occupational safety organizations (information in HAZ-MAP database). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). This compound produced by P. roqueforti is a sesquiterpenoid mycotoxin. PR-toxin produced acute toxic effects in animals via an increase of capillary permeability and direct damage to lungs, heart, liver and kidneys. In this review no standard toxicity studies have been found. Some studies evaluating the effects on health status and animal performance found that PR-toxin did not affect rumen fermentation pattern Ames tests with TA 98 and TA100 strains. Positive results were also obtained in Rec-assay in Bacillus subtilis and gene conversions assays in Saccharomyces cerevisiae and Neurospora crassa. Various LD 50 (previous to 1990) in rodents and with different routes of exposures are collected in ChemIDplus database. The LD 50 ranged in mice from 2 mg/kg (intravenous and intraperitoneal administration) to 72 mg/kg in after oral administration. In rats, LD 50 ranged from 8.2 mg/kg (intravenous) to 11.6 mg/kg (intraperitoneal). A LD LO of 115mg/kg has been reported in rats. There have been reported the conditions of PR-toxin production, which only happens in stationary cultures, within the pH range of 4.5-9.0 and temperature range of 10º-30ºC with the optimum temperature at 24ºC. In the database it is also included the PR-toxin biosynthetic pathway by P.roqueforti, through the action of aristolochene synthase. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 41 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Roquefortine-type alkaloids are produced by several Penicillium species including species of industrial applications such as P. roqueforti (Sumarah et al., 2005) and P. chrysogenum (Bringmann et al., 2005) . P. roqueforti roquefortine cluster contains only four genes (rds, rdh, rpt, and gmt) encoding the roquefortine dipeptide synthetase, roquefortine D dehydrogenase, roquefortine prenyltransferase, and a methyltransferase, respectively. Silencing of the rds or rpt genes by the RNAi strategy reduced roquefortine C production by 50%, confirming the involvement of these two key genes in roquefortine biosynthesis. P. roqueforti lacks the genes that encode the enzymes for the conversion of roquefortine C to roquefortine L (or glandicoline A) and meleagrin, a difference between other Penicillium species with the same gene cluster as P. chrysogenum. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). This is a trichothecene metabolite produced by several species of Fusarium such as F. venenatum. The metabolic route of this compound has been studied and postulated that 2a-hydroxytrichodiene is the first oxygenated step in its biosynthesis (Zamir et al. 1999 ). Secalonic acid D (SAD), a metabolite of P. oxalicum, although it has been reported that can be produced by A. aculeatus (Gao et al., 2014) . In this review, no standard toxicity studies have been found. However, some mechanistically-relevant articles and reviews have been retrieved from the systematic search. Secalonic acids, mainly secalonic D, have been evaluated for potential anticancer activity in vitro (antiangiogenic activity, cytotoxicity, ABCG2 downregulation, cell signaling disruption, DNA topoisomerase I inhibitor, apoptosis, cell cycle arrest at G1). In vivo, a preliminar preclinical validation and mechanistic definition of the antiangiogenic activity of secalonic acid D with potential application as a cancer-selective therapeutic agent was carried out. Treatment of SAD at all experimental doses was nontoxic in solid tumor model animals (mice) as no mortality (0/7) occurred during the course of the experiment (Guru et al., 2015) . Secalonic A has shown to antagonize the cytotoxicity of colchicine in the rat cortical neurons through inhibition of phosphorylation of JNK and p38 MAPKs, calcium influx, and the activation of caspase-3. Another set of articles found focused on unraveling the mechanism of teratogenesis (cleft palate induction) of SAD in mice. Some information related to genotoxic effects of secalonic acid D can be found in CCRIS (updated in 1993) and GENE-TOX (updated in 1995) databases: negative results with and without metabolic activation were obtained in an Ames test (TA 100) (study from 1992). No conclusions were drawn from a previous study performed in 1978. An LD LO (15.6 mg/kg, mouse, intraperitoneal) (from 1952) has been found in ChemIDplus database. As mentioned in the previous section, Trichodermin is a trichothecene (4β-acetoxy-12, 13-epoxy-Δ9trichothecene). A review of the understanding of the relationship between structure and known function of these compounds has been found (Alexander NJ et al., 1998) . No standard toxicity studies have been found in this review. Some reports evaluated trichordermin for its potential therapeutic effects as antifungal or antitumoral. An LD 50 (500 mg/kg, mouse, intraperitoneal and subcutaneous) (from 1986) have been found in ChemIDplus database. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 44 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). This compound has been identified as a secondary metabolite of A. melleus (Neidig et al., 2013) . Xanthomegnin has shown to have potent inhibitory activity in the inducible nitric oxide synthase There are several recognised toxic compounds, some of them legislated under European regulations for food and feed and that have been reported to be produced by species of fungi used in industrial fermentations. Some of their characteristics and biosynthesis are described below. Aflatoxins are one of the main mycotoxins, produced by some species of Aspergillus Section Flavi. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 45 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Aflatoxin B1 is the most common in food and widely studied mycotoxin. It is produced primarily by the two species: A. flavus and A. parasiticus, which are especially found in areas with hot and humid climates. A. flavus is ubiquitous, favouring the aerial parts of plants (leaves, flowers) and produces B aflatoxins. A. parasiticus produces both B and G aflatoxins. Aflatoxins are classified by the International Agency for Research on Cancer in the Group 1 "carcinogenic to human", producing liver cancer (IARC, 2012). Aflatoxins are also considered as "known to be human carcinogens" by the NTP (2016). Based on the existing evidence related to the toxicological effects of these mycotoxins, The European Regulation (EC) 1881/2006 and its modifications have established maximum permitted levels in certain foodstuffs, such peanuts, pistachios, tree nuts, cereals, maize, rice and milk. The section Flavi of genus Aspergillus also includes A. oryzae and A. sojae, which are used for the production of various industrial enzymes and fermented foods in eastern Asia. Although is generally recognized by the scientific community that Aspergillus oryzae and A. sojae do not produce aflatoxins, some controversy has arisen in the past from reports by some authors (Atalla et al., 2003) . These fungi are taxonomically similar to aflatoxin-producing species; therefore, it is necessary to determine whether these strains have the potential to make toxins. Amadi and Adeniyi (2009) The main conclusion from this data is that aflR gene could be examined to assess possible aflatoxin production by industrial strains within the group Aspergillus section Flavi. Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 46 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). These secondary metabolites are produced by Fusarium species, typical mycotoxin producing fungi. They are predominantly found in cereal grains and their products. Beauvericin and enniatins possess a wide range of biological activities. These substances are known as ionophores, antimicrobial and antibiotic compounds, enzyme inhibitors, and as compounds inducing oxidative stress. They also have cytotoxic activity towards different cell types inducing apoptosis. There are no reports on mycotoxicoses associated with these toxins, although different toxic actions are known in vitro for enniatins and beauvericin, probably related to their ionophoric properties. For beauvericin, the LD 50 for acute toxicity was 100 mg/kg b.w. upon oral administration to mice. An LD 50 of 350 mg/kg b.w. was reported for fusafungine (a mixture of enniatins) in mice upon oral administration. A sub-acute toxicity study on enniatin A with some limitations showed no adverse effects. Beauvericin is a strong insecticidal product (EFSA Journal 2014c). Citrinin is a nephrotoxic mycotoxin produced by several species of the genera Aspergillus, Penicillium and Monascus. It has been implicated in porcine nephropathy and has been found as a natural contaminant of corn, rice, wheat, rye, barley, and oats. Citrinin was classified as group 3 (not classifiable as to its carcinogenicity to humans) by IARC (IARC, 1987) and was more recently evaluated by EFSA (EFSA Journal 2012b). Citrinin is a polyketide that has been reported to be produced by the two fungal species P. citrinum, P. chrysogenum, but besides citrinin, a large number of citrinin derivatives have been isolated from different fungal species, citrinin decomposes during heat treatment to form other complex compounds, such as citrinin H1 and citrinin H2, respectively with higher and weaker cytotoxicity than the original citrinin. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). There are some reports on the biosynthesis of citrinin by P. citrinum and the effect of several process conditions on the production of this mycotoxin by microorganisms used in industrial fermentations Ergot alkaloids (EA) belong to a diverse group of mycotoxins with neurological effect on humans, but also with a range of biological activities that have important applications in medicine and agriculture. EAs are produced by a variety of plant associated fungi, mainly of the genera Claviceps and Aspergillus. In this review it has been found to be produced by A. japonicus ( The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). modifications). Recently a scientific statement on the increase of risk for public health related to a possible temporary derogation from the maximum level fumonisins in maize and maize products has been published (EFSA Journal 2014a). NaCl, or 10-20% sucrose increased the production of the toxin but glycerol has an opposite effect. It has been reported that some of the most frequently used strains in industry, A. niger NRRL The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). (1996). It gave positive results in several genotoxicity assays and was able to induce induced papilloma and carcinoma of the oesophagus and forestomach in mice and rats (IARC, 1996) . The biosynthesis of fusarin C has been partially resolved and is performed by a polyketide synthase/nonribosomal peptide synthetase system. In this review, it has been found a report elucidating the biosynthesis of Fusarin C by the species F. venenatum. A homologous gene of fusA in F. moniliforme is responsible for the early stages of fusarin biosynthesis in F. venenatum (Song et al., 2004) . Expression of the pks gene appears to be correlated with OTA production in A. niger; therefore this finding provides data to find a route for avoiding the production of OTA in industrial strains. The genome sequencing of A. niger strain CBS 513.88 revealed the presence of a pks gene An15g07920 that has a strong similarity to the pks gene of A. ochraceus involved in OTA biosynthesis. It has been reported that a fragment of this gene is specific for ochratoxigenic strains of A. niger and therefore deletion of this fragment should be sought for avoiding OTA in industrial processes (Shinohara et al., The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Regarding the production of OTA by P. nordicum, there is a study that shows the effect of sodium chloride on the regulation of ochratoxin A biosynthesis in Penicillium species. High amounts of ochratoxin A are produced by P. nordicum over a wide concentration range of NaCl (5 to 100 g/L), with an optimum at about 20 g/L on YES medium (Schmidt-Heydt and Geisen, 2007). Patulin is a toxic chemical contaminant produced by several species of mold, especially within Aspergillus and Penicillium. It is the most common mycotoxin found in apples and apple-derived products such as juice, cider, compotes and other food intended for young children. Exposure to this Potential toxigenic capacities of microorganisms used for industrial production of enzymes and additives www.efsa.europa.eu/publications 53 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Penicillic acid (PA) is a polyketide mycotoxin produced by several species of Aspergillus and Penicillium. This mycotoxin is toxic in experimental animals and has also been reported to be carcinogenic. It can cause generalized hepatic necrosis in the mouse and cytotoxicity in cultured cells, including hepatocytes. The cytotoxicity of penicillic acid was studied in rat alveolar macrophages (AM) in vitro Sorenson et al., 1986) . The data demonstrate that penicillic acid is toxic to rat alveolar macrophages in vitro and suggest the possibility of a respiratory hazard to agricultural workers exposed to contaminated grain. This mycotoxin was also evaluated for its toxicity in broiler chickens (Huff et al., 1980) . The data suggest that penicillic acid by itself has little toxicity in chickens (less than 1% compared with aflatoxin). Sterigmatocystin is a mycotoxin produced mainly by Aspergillus fungi, and is an intermediate in the biosynthesis of aflatoxin B1. Major producing microbes include A. versicolor and A. nidulans The structure and the bioactivity of sterigmatocystin are similar to those of aflatoxin, but its toxicity is weaker than aflatoxin and is observed in the liver and the lung. Its toxicity is said to be 1/125 and the carcinogenicity to be 1/250 of aflatoxin B1, and its acute toxicity is low (The Pharmaceutical Society of Japan: Methods of Analysis in Health Science, 2010). Carcinogenicity is reported in animal studies. www.efsa.europa.eu/publications 54 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Sterigmatocystin has been detected in feed materials including maize, wheat, barley, milo, cassava, corn gluten feed, corn gluten meal, bran, and soybean meal. Trichothecenes are one of the major classes of mycotoxins, produced by several fungi genera including Fusarium, Myrothecium, Spicellum, Stachybotrys, Cephalosporium, Trichoderma, and Trichothecium and are potent inhibitors of eukaryotic protein synthesis. Trichothecenes are a family of over 200 toxins with a common tricyclic 12,13-epoxytrichothec-9-ene (EPT) core structure that have been classified into four groups (Types A, B, C, and D). Type A trichothecenes include T-2 toxin, neosolaniol, trichodermin, diacetoxyscirpenol (DAS), and harzianum A. In this review, several reports on the production of these toxins by the microorganisms within the scope of the review, such as F. venenatum (DAS) ( The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Zearalenone (ZEA) is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. It is frequently implicated in reproductive disorders of farm animals and occasionally in hyperoestrogenic syndromes in humans. There is evidence that ZEA and its metabolites possess oestrogenic activity in pigs, cattle and sheep. However, ZEA is of a relatively low acute toxicity after oral or interperitoneal administration in mice, rat and pig. Although ZEA is toxic, it globally presents a potential danger for animal and human health only when it is absorbed in high amounts or over a long time of exposure (Zinedine et al., 2007) The Joint FAO/WHO Expert Committee on Food Additives (JECFA) 2016 established a provisional maximum tolerable daily intake (PMTDI) for ZEA of 0.5 µg/kg of body weight. Potentially toxic substances produced by bacteria that have not been fully evaluated from the toxicological point of view have been identified in this review. The majority are associated with virulence factors, such as signaling molecules (that are only elicit in the presence of competitors), or adhesion proteins that allow bacteria the attachment, favoring the formation of biofilms and therefore, providing more resistance to external aggression. Moreover, information on possible effects of the LPS (lipopolysacharide endotoxins), released by the microorganism species of the scope of the project, would need to be taken into account as relevant information. A short description of the most relevant compounds synthesized by bacteria within the scope of this project is given below. Cytolysin A (ClyA) is a hemolytic protein of Escherichia coli K-12, they damage host cells by forming holes in the cytoplasmic membrane, which may result in cell death and osmotic cell lysis. It has been reported that this pore-forming cytotoxic protein encoded by the clyA gene protein, is not expressed under normal laboratory conditions. Genetic analysis suggested that clyA is silenced by the nucleoid protein H-NS. Purified H-NS protein showed preferential binding to clyA sequences in the promoter region. In this review, it has been found a study that test the (Table 4) . www.efsa.europa.eu/publications 56 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Most enzymes and genes related to the biosynthesis and export of lipopolysaccharide have been identified in E. coli, and they are shared by most Gram-negative bacteria based on available genetic information. However, the detailed structure of lipopolysaccharide differs from one bacterium to another, suggesting that additional enzymes that can modify the basic structure of lipopolysaccharide exist in bacteria, especially some pathogens. These structural modifications of lipopolysaccharide are sometimes tightly regulated. They are not required for survival but closely related to the virulence of bacteria. The first three enzymes LpxA, LpxC and LpxD of the LPS biosynthetic pathway have been purified, and their structures have been characterised by X-ray diffraction and NMR methods. Based on the structural information from these proteins, research into developing new antibiotics is being carried out. LPS from well-known species can cause diseases such as septic shock, multiple organ dysfunction and failure. Understanding the biochemistry of LPS modifications and their impact on pathogenesis could lead to novel treatment options for these diseases. www.efsa.europa.eu/publications 57 EFSA Supporting publication 2017:EN-1274 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Phenazines are pigmented, redox-active, heterocyclic, nitrogen containing molecules secreted by a considerable number of .Streptomyces, (Sarmin et al., 2013) and multiple fluorescent Pseudomonas . Several derives have been found in this review, such as 1-Hydroxyphenazine , Phenazine-1-carboxylic acid and Endophenazine A. Phenazines display a broad spectrum of (toxic) activity toward prokaryotic and eukaryotic organisms, varying according to the nature and position of the substituent on the heterocyclic ring. They are considered as virulent factor pf P. aeruginosa (Ballok and O'Toole, 2013) , but no standard toxicity data have been found in this report for these substances. Phenazines are considered redox-active compounds as well as a cytotoxic pigment. Pyocyanin, (1-hydroxy-5-methylphenazine) is the beststudied natural phenazine. In this review it has been found that several of the articles related to virulence of P. aeruginosa, do not include toxicological evaluation. Others are related with cystic fibrosis lung (patients are specially affected by P. aeruginosa infection). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). Pyocianin (5-N-methyl-1-hydroxyphenazine), the first and most-studied member of the phenazine family,. Phenazines are low-molecular-weight secondary metabolites including nitrogen-containing heterocyclic pigments. Almost all phenazines exhibit broad spectrum activity against plant pathogenic bacteria and fungi. Pyocianin is produced only by P. aeruginosa and 90 to 95% of P. aeruginosa strains produce pyocyanin. This specificity that has been useful in the rapid diagnosis of this opportunistic pathogen. Pyocianin produced in the rhizosphere of plants plays an important role in the biological control activity of P. aeruginosa against Fusarium wilt of chickpea and Pythium damping off of bean. This blue phenazine is one of the major virulence factors in this pathogen, contributing to both acute and chronic infections. It suppresses lymphocyte proliferation, damages epithelial cells as a consequence of hydroxyl radical formation, inactivates protease inhibitors (consequently causing tissue damage by endogenous proteases), and targets multiple cellular functions. The redox-active pyocianin (PCN) secreted by the respiratory pathogen P. aeruginosa generates reactive oxygen species (ROS) and causes oxidative stress to pulmonary epithelial cells. Pyocianin is able to produce oxidative stress damage in mammalian tissues. Several toxicological endpoints were dectected in mechanisitic studies (related mainly with sepsis and bacteria pathogenicity/virulence): neurotoxicity, haemotoxicity, inhibition of ATPase and immunotoxicity (neutrophil extracellular traps promotion). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). fermentation as well as biosynthetic pathways, which can help to retrieve useful information in future searches. A customized technology based on a collaboration platform (iWatch) capable of extracting information from different web databases. This platform provides two tools: a crawler tool implemented and configured to collect and classify all documents as required by the search strategy and a user interface parameterized to implement the working methodology. Both allow continuing with extraction of information efficiently. A working methodology based on inclusion/exclusion criteria to allow experts the review, the analysis and classification of all extracted documents. This can be useful to continue efficiently with the same workflow in future searches. A validated Database to store all data extracted by experts regarding taxonomy, process conditions, biosynthetic pathways and toxicology on non-QPS microorganisms. Also a tool to extract, convert and store the information retrieved in collaboration with the platform (iWatch) integrated into the database. All can be useful to continue efficiently updating the database with new information included by the experts. A report on more than 400 bioactive secondary metabolites produced by industrial microorganisms have been identified and recorded. Most of these compounds have been reported in relation to some metabolic aspects and studies related to their toxicity were not found, and therefore only a small part of the identified compounds are included in the database, however, new information could be gathered in the future and the name of this compounds could be used as new keywords for future searches. Considering the above aspects, the sustainability of the database can be ensured by updating it periodically (every year) maintaining the same structure. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). In the present project, it has been developed an integrative and useful database for supporting safety assessment that includes relevant and accurate information about taxonomical characterisation and potential toxigenic capacities of microorganisms used for the industrial production of feed additives and food enzymes. The structure of the data model and its terminology includes the use of EFSA standard coding system. The data model has been aimed to include the following information:  Description of microbial species used to produce food enzymes and feed additives which have not been recommended for Qualified Presumption of Safety (QPS) status, with its main identifiers: the current scientific name, taxon assignation, synonyms, existing methods for the taxonomical characterisation and accession numbers for housekeeping genes. The contents of the database have been retrieved by the performance of a systematic search that has been aided by the use of an "ad hoc" automatic tool. For the microbial taxonomic review, a total of 123 scientific documents have been obtained to extract the relevant information for the database. For the identification of secondary metabolites, 22970 scientific documents have been recovered combining the searching platform and manual searching, classified by microorganism species names and systematically revised, to obtain pertinent data. A total of 411 scientific documents were selected that contain relevant data on potentially toxic secondary metabolites. A total of 474 bioactive secondary metabolites were found to be produced by the microbial species within the scope of this project, from which 59 were selected for further searches for data on their toxicity and biosynthesis. Fungal species are the most predominant group to produce toxic metabolites, including well known mycotoxins. However, in the majority of the cases, industrial strains contain a natural or artificially induced safeward mutation or genetic modification which prevents the production of the toxin under defined fermentation conditions. The majority of secondary metabolites produced by fungi found in this review are studied for their biotechnological and biopharmaceutical potential due to their properties such as antimicrobial, antinematode, antitumor, etc. The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 1 Included in Directive 2002/32/EC 2 IARC agent "Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X)" 3 IARC agent "Fusarium moniliforme, toxins derived from (fumonisin B1, fumonisin B2, and fusarin C)" 4 Carcinogenic to humans 5 Not classifiable as to its carcinogenicity to humans 6 Possibly carcinogenic to humans cytolysin A -- -- -- -- endophenazine A -- -- -- -- festuclavine Appendix F -List of excluded articles. Level 2 aculeatusquinones A-D bioactive compound [1] aculenes A-D (sesquiterpenoid) bioactive compound [3] asperaculane A (sesquiterpenoid) bioactive compound [3] asperaculane B (sesquiterpenoid) bioactive compound [3] atraric acid bioactive compound [1] nordaucane one (sesquiterpenoid) bioactive compound [3] okaramines H and I insecticidal activity [4] secalonic acid D mycotoxin [3] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. Aspergillus japonicus asperparalines bioactive compound [5, 6, 7] chanoclavine-I ergot alkaloids intermediate [8] cycloclavin ergot alkaloid [9] ergot alkaloids mycotoxin [8] festuclavine ergot alkaloid [9] neoxaline alkaloid [10, 11] ochratoxin A mycotoxin [12] preparaherquamide alkaloid [13] secalonic acid F mycotoxin [14, 15] sterigmatocystin mycotoxin [16] Aspergillus melleus aspyrone nematicidal activity [17] mellamide insecticidal activity [18] ochratoxin A mycotoxin [18] viomellin bioactive compound [18] xanthomegnin bioactive compound [18] Aspergillus niger anthraquinones bioactive compound [19] asperenone bioactive compound [20] aspernigerin bioactive compound [21] aspernigrins bioactive compound [22] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. aurasperone B ;F; G naphtho-gamma-pyrone [23, 24] campyrone A;B;C bioactive compound [25] coprogen B iron chelator [26] desmethylkotanin bioactive compound [23] ferrichrome iron chelator [26] fonsecin bioactive compound [22] Aspergillus niger fumonisin; B2; B4 mycotoxin [23, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] funalenone collagenase inhibitor [31] hexylitaconic acid plant growth regulator [38] kotanin bioactive compound [23, 31, 34] malformin A; C cause malformations in plants [22, 23, 31, 34] maltoryzine mycotoxin [39] naphtho-gamma-pyrones toxic aromatic compounds [31, 34, 40] nigerasperone A;B;C naphtho-gamma-pyrones [41] nigerazine B plant growth inhibitor [42] nigragillin alkaloid [40, 42] ochratoxin A;alpha mycotoxin [23, 24, 29, 31, 33, 34, [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] orlandin bioactive compound [23, 40] oxalates and oxalic acid toxic organic compound [54] [55] [56] [57] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. pyranonigrin A antioxidative activity [23, 31] Aspergillus niger rubrofusarins bioactive compound [22] saponins foaming glucoside [19] tensidol B antimicrobial compound [23, 31] tensyuic acids antibiotic [38] yanuthone K;L;M;X2 antifungal compound [58] Aspergillus oryzae 13-desoxypaxilline intermediate metabolite [59] 2-oxocyclopiazonic acid less toxic analogue of CPA [60] 3-nitropropionic acid mycotoxin [42] aflatoxins B1 and B2 mycotoxin [61, 62] aspergillomarasmine phytotoxins [42] aspirochlorine inhibitor of fungal protein synthesis [63] astellolides A; B; C-E; F-I sesquiterpenoids [64] bisdethio(bismethylthio)gliotoxin bioactive compound [65] cyclo-(Pro,Val) bioactive compound [65] cyclo-(Tryp,Tyr) bioactive compound [65] cyclopiazonic acid mycotoxin [42, 60, [65] [66] [67] [68] [69] deoxynivalenol (DON) mycotoxin [62] ditryptophenaline alkaloid [65] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. kojic acid tyrosinase inhibitor [42, 65, 66, 70] Aspergillus oryzae maltoryzine cause food poisoining in cows [42] oryzaeins bioactive compound [71] parasiticolide A secondary metabolite [59] pseurotin A bioactive compound [65] speradines B -H bioactive compounds [72, 73] T-2 toxin mycotoxin [62] uridine bioactive compound [65] violacetin bioactive compound [42] zearalenone mycotoxin [62] Aspergillus sojae aflatoxin mycotoxin [74] glyceollins isoflavone bioactive compound [ reports not found antharanilic acid bioactive compound [79] cyclo-(dehydroala-l-Leu) bioactive compound [79] cyclo-(l-Pro-l-Leu) bioactive compound [79] cyclo-(l-Pro-l-Tyr) bioactive compound [79] Cellulosimicrobium cellulans cyclo-(l-Pro-l-Val) bioactive compound [79] L-phenylalanine bioactive compound [79] Chaetomium erraticum reports not found 22E,24R)-ergosta-7,22-diene-3β,5alfa,6beta-triol antimicrobial substance [80] adenosine antimicrobial substance [80] chaetochromin A antimicrobial substance [80] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. chaetoquadrin antimicrobial substance [80] ergosterol antimicrobial substance [80] eugenitol antimicrobial substance [80] glycerol monopalmitate antimicrobial substance [80] indole-3-carboxylic acid antimicrobial substance [80] p-hydroxylbenzaldehyde antimicrobial substance [80] Cryphonectria parasitica Syn. Endothia parasitica cryparin hydrophobin protein [82, 83] cryphonectric acid phytotoxin [84] diaporthin produce canker in leaves [84] Cryphonectria parasitica L-p-hydroxyphenyllactic acid (HOPLA) phytotoxin [84] orthosporin produce canker in leaves [84] phleichrome pigment (quinone) [85] Chryseobacterium proteolyticum endotoxin (virulence factor), low production [86] Disporotrichum dimorphosporum reports not found reports not found Syn. Cryphonectria parasitica Escherichia coli K-12 curli proteins adhesion protein [87] cytolysin A (ClyA) cytotoxin [88, 89] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. lipopolysaccharide (LPS) or endotoxin endotoxin [90] SheA hemolysin cytotoxin [91] Tsh protein hemagglutinin (virulence factor) [92] Flavobacterium multivorum reports not found apotrichothecene mycotoxin (trichothecenes) [93] beauvericin mycotoxin [94] butenedioic acid bioactive compound [95] culmorin sesquiterpene [93] culmorone sesquiterpene [93] diacetoxyscirpenol mycotoxin (trichothecenes) [93, 95, 96] enniatin B sesquiterpene [93] fusarin C mycotoxin [97] hexadecane bioactive compound [95] hexadecanoc acid bioactive compound [95] Fusarium venenatum imidazole bioactive compound [95] isotrichodermin mycotoxin (trichothecenes) [93] isotrichodermol mycotoxin (trichothecenes) [93] phenol, 2,5-bis (1,1-dimethylethyl) bioactive compound [95] phthalic acid bioactive compound [95] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. sambucinol mycotoxin (trichothecenes) [93] tetradecanoic acid bioactive compound [95] Geobacillus caldoproteolyticus reports not found antimicrobial polipeptide antimicrobial [98] Geobacillus stearothermophilus reports not found reports not found reports not found Syn. Penicillium lilacinum reports not found reports not found anti-phytopathogenic compounds [105] nematicidal compounds [106] Penicillium camemberti cyclopiazonic acid mycotoxin [107] Penicillium chrysogenum (3R, 4R)-3,4,8-trihydroxy-3,4-dihydronaphthalen-1 (2H)-one bioactive compound [108] (9Z,12Z)-2,3-dihydroxypropyl octadeca-9,12-dienoate neuroprotective effect [109] (E)-N-(4-hydroxystyryl) formamide bioactive compound [108] (Z)-N-(4-hydroxy styryl) formamide bioactive compound [108] 1,2,4 dihydroxy 6 methylbenzoyl glycerol antifungal compound [110] 11 bromoroquefortine C bioactive compound [111] 2,2,4 dihydroxy 6 methylbenzoyl glycerol antifungal compound [110] 2-(4-hydroxyphenyl)acetamides bioactive compound [112] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. 2-(4-hydroxyphenyl) acetonitrile bioactive compound [108] 2,3-dihydrosorbicillin neuroprotective effect [109] 2-[(2-hydroxypropionyl) amino] benzamide neuroprotective effect [109] 24 epicyclocitrinol 9 steroid [113] 2S,3R oxaline bioactive compound [108] 4-(2-hydroxyethyl) benzene-1,2-diol bioactive compound [108] bisvertinolone bioactive compound [114] BMS 182123 TNF-alpha inhibitor [115] chrysogenamide A neuroprotective effect [109] chrysotriazoles A and B bioactive compound [112] circumdatin G neuroprotective effect [109] Penicillium chrysogenum citrinin mycotoxin [116] [117] [118] conidiogenones diterpenes [119] conidogenol diterpenes [119] cyclocitrinol steroid [113] emodin bioactive compound [108, 120] ergosterol endoperoxide bioactive compound [121] erythro 11 hydroxyneocyclocitrinol steroid [113] linolenic acid bioactive compound [121] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. lovastatin bioactive compound [122] meleagrin bioactive compound [120, 123] methyl 2-(4-hydroxyphenyl) acetate bioactive compound [108] N 4 hydroxystyryl formamides bioactive compound [112] neocyclocitrinols A-D steroid [113] norcyclocitrinol A steroid [113] ochratoxin A mycotoxin [124, 125] oxosorbicillinol bioactive compound [114] penicillin G antibiotic [123] penicimonoterpene antifungal compound [110] penicisteroid A, B cytotoxic polyoxygenated steroids [126] Penicillium chrysogenum penicitide A, B cytotoxic and antimicrobial [110] penicitols A and C citrinin analogues [127] penimethavone A flavone [128] penixanacid A xanthone derivative [127] pesudocyclocitrinol A cytotoxic polyoxygenated steroids [113] phenoxyacetic acid antifungal compound [129] phenylacetic acid citrinin analogues [129] PR toxin sesquiterpenoid mycotoxin [130] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. quinazolinones bioactive compound [112] roquefortine C mycotoxin [114, 120, 123, [131] [132] [133] rugulosin bioactive compound [134] secalonic acid mycotoxin [120, 135] skyrin bioactive compound [134] Penicillium chrysogenum sorbicillactones A and B bioactive compound [114] sorbicillin bioactive compound [114] sorbicillinol bioactive compound [114] sorbivinetone bioactive compound [114] xanthocillin X bioactive compound [123] Penicilium citrinum (3S)-4,6-dihydro-8-mehoxy-3,5-dimethyl-6-oxo-3H-2benzopyran bioactive compound [136] (3S)-6-hydroxy-8-methoxy-3,5-dimethylisochroman bioactive compound [136] 1,2,3,11b-tetrahydroquinolactacide bioactive compound [136] 2-(hept-5-enyl)-3-methyl-4-oxo-6,7,8,8a-tetrahydro-4Hpyrrolo[2,1-b]-1,3-oxazine bioactive compound [137] 2,4,5-trimethylbenzene-1,3-diol bioactive compound [137] 2,4-dihydroxy-3, 5,6-trimethylbenzoic acid bioactive compound [137] 3-methoxy-2-methyl-4H-pyran-4-one bioactive compound [137] 4-hydroxyquinolin-2(1H)-one bioactive compound [136] 5-methyl alternariol ether bioactive compound [137] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. 6-methylcurvulinic acid bioactive compound [136] 8-methoxy-3,5-dimethylisoquinolin-6-ol bioactive compound [136] ω-hydroxyemodin bioactive compound [137] alternariol bioactive compound [137] arohynapene D bioactive compound [136] citrinamide bioactive compound [136] citrinin, H1, H2 mycotoxin [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] citriquinochroman citrinin derivative [136] Penicilium citrinum conioxanthone A bioactive compound [137] decarboxycitrinin citrinin derivative [137, 142] decarboxydihydrocitrinone citrinin derivative [145] dicitrinin citrinin derivative [142] dicitrinol A and B citrinin derivative [142] ergot alkaloids mycotoxin [148] indole acetic acid methyl ester bioactive compound [136] methyl 8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate bioactive compound [137] methylpenicinoline bioactive compound [136] mevastatine statins [149] Pen c 1, 2, 3, 13, n18, 22, 24, 30, 32 allergen [150] [151] [152] [153] [154] [155] [156] [157] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. penicinoline bioactive compound [136] penicitrinol B, C, D, E13, G, L cytotoxic compound [142, 145, 158] penicitrinone A cytotoxic compound [158] penidicitrinin B cytotoxic compound [158] perinadine A alkaloid [137, 159] phenol A, phenol A acid bioactive compound [142] Penicilium citrinum quinolactacide TNF inhibitor [136, 160] quinolactacin A TNF inhibitor [137] redoxcitrinin citrinin derivative [137] sclerotinin A, B bioactive compound [137] sydowinin B bioactive compound [137] tanzawaic acid A, B, F, G, H anti-inflammatory activity [136, 147] trichodermamide bioactive compound [136] tricitrinol A, B bioactive compound [142] vanillic acid bioactive compound [136] Penicillium decumbens (16R)-16-hydroxy-24-epi-cyclocitrinol bioactive compound [161] Syn. Penicillium indicum 12R-hydroxycyclocitrinol bioactive compound [161] 20-O-methyl-24-cyclocitrinol bioactive compound [161] 20-O-methyl-24-epi-cyclocitrinol bioactive compound [161] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. 22-acetylisocyclocitrinol A bioactive compound [161] 24-epi-cyclocitrinol bioactive compound [161] cyclocitrinol bioactive compound [161] Penicillium decumbens cyclopenicillone bioactive compound [161, 162] decumbenones A and B fungal inhibitor [163] isocyclocitrinol A, B bioactive steroid [161] neocyclocitrinol A, B, C, D bioactive steroid [161] OH-15 derivative of 24-epi-cyclocitrinol bioactive compound [161] versiol fungal inhibitor [163] Penicillium funiculosum 2,3,4 trihydroxybutanamide antimicrobial compound [164] Syn. Talaromyces funiculosum chrodrimanins I and J bioactive compound [165] citreoviridin mycotoxin [166] gibberellins (diterpenoid acids) plant growth promoter [167] mitorubrinic acid derivative of roquefortine [168, 169] OR 1 a mixture of esters of glyceric acid [169, 170] patulin mycotoxin [171] prenyleudesmane diterpenoids 1 and 2 terpenoid [172] siderophores iron chelator [173] Penicillium funiculosum wortmannin cytotoxic steroid [174] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. leucinostatins, A statin [103, 104, 175] Syn. Purpureocillium lilacinum phytotoxins agonist to nematodes [176] Syn. Paecylomices lilalicinus (S)-6-((1S,2S)-1,2-dihydroxypentyl)-4-methoxy-5,6-dihydro-2H-pyran-2-one antitumor [177] 5 bromoochrephilone bioactive compound [178] 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one bioactive compound [177] 8-O-methylsclerotiorinamine bioactive compound [179] dechloroisochromophilone II-IV (azaphilone) bioactive compound [177, 178] epi-isochromophilone III (azaphilone) bioactive compound [177] ergosterol bioactive compound [177] ergosterol peroxide bioactive compound [177] isochromophilone I-IV, VI, VIII (azaphilone) bioactive compound [177, 178, 180] Isorotiorin (azaphilone) bioactive compound [178] Ochrephilone (azaphilone) bioactive compound [177] sclerotioramine (azaphilone) bioactive compound [177] Penicillium multicolor sclerotiorin (azaphilone) bioactive compound [177, 180] Penicillium nordicum ochratoxin A mycotoxin [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. reports not found Syn. Penicillium chrysogenum 1-hydroxyeremophil-7(11),9(10)-dien-8-one [192] andrastins A-D bioactive compounds [192] [193] [194] [195] aristolochene in the biosynthetic route of PR toxin [130, 196] eremofortines A-E alkaloid [197] festuclavine ergot alkaloid [197] [198] [199] isofumigaclavines A and B ergot alkaloids [197, 198] marcfortines derivatives of roquefortine [195, 200] mycophenolic acid mycotoxin [192, [200] [201] [202] [203] [204] [205] [206] [207] [208] patulin mycotoxin [204, 205, 208] penicillic acid mycotoxin [204, 205, 208] PR toxin mycotoxin [130, 192, 193, 196, 198, 200, 205, [209] [210] [211] [212] roquefortine A, C, D mycotoxin [192, 193, 195, 197, 198, 200, 204, [206] [207] [208] [209] , 212-219] reports not found Penicillium sclerotiorum cyclopenol benzodiazepine alkaloid [220] Syn. Penicillium multicolor ergosterol bioactive alkaloid [220] ergosterol peroxide bioactive alkaloid [220] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. isochromophilone VI antimicrobial substance [221] pencolide antimicrobial substance [221] sclerotiorin aldose reductase inhibitor [221, 222] verrucosidin bioactive alkaloid [220] viridicatin bioactive alkaloid [220] viridicatol bioactive alkaloid [220] Pichia angusta reports not found 2-aminoacetophenone virulence factor [223] alkylquinoline signaling molecule [224] CFTR inhibitory factor virulence factor [225, 226] elastase [227] ETA [228] ExoS virulence factor [228] [229] [230] [231] ExoT virulence factor [228, 229] Exotoxin A virulence factor [227, 232] ExoU virulence factor [233] [234] [235] [236] [237] L-2-amino-4-methoxy-3-butenoic acid [238] lipopolysaccharide (LPS) endotoxin [239, 240] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. lipotoxin [241] metallo-β-Lactamase antimicrobial resistance factor [242] PcrV (type III secretion system) virulence factor [243] phenazine and derivates virulence factor [244] [245] [246] Ref. reports not found Syn. Klebsiella planticola reports not found reports not found gamma-linolenic acid methyl ester (methyl GLA) antiapoptotic effect [275] linoleic acid cytotoxic and antiinflamatory [276] Rhizopus oryzae linolenic acid methyl ester cytotoxic and antiinflamatory [276] palmitic acid cytotoxic and antiinflamatory [276] palmitic acid methyl ester cytotoxic and antiinflamatory [276] Rhi o 1 allergen [277] Sphingobacterium multivorum reports not found reports not found bacteriocin antibacterial compound [278] pyranones antitumor [279] rebeccamycin (indolocarbazole alkaloids) antitumor [280] siderophore iron chelant [278] terpene bioactive compound [278] Streptomyces aureofaciens reports not found Ref. albofungin antibiotic [281] chloroalbofungin antibiotic [281] chrestoxanthones A-C antifungal [281] Streptomyces chromofuscus carazostatin carbazole alkaloids [282] Streptomyces chromofuscus herboxidiene bioactive compound [283] Streptomyces cinnamonensis 2-demethylmonensihs A, B minor congeners of monensins [284] arcyriaflavin E indolocarbazole alkaloid [285] endophenazine A antimicrobial compound [286, 287] furanonaphthoquinone I (FNQ I) bioactive compound [286, 287] Streptomyces cinnamoneus reports not found Streptomyces lividans colabomycin E anti inflammatory agent [289] Streptomyces mobaraensis bleomycin anticancer substance [290] Streptomyces murinus reports not found congocidine analogs (pyrrolamide compounds) antibiotics [291] congocidine (pyrrolamide compound) antibiotic [292] disgocidine (pyrrolamide compound) antibiotic [292] distamycin (pyrrolamide compound) antibiotic [291, 292] Streptomyces olivochromogenes reports not found Ref. reports not found granaticin A, C bioactive polyketide [293, 294] Streptomyces violaceoruber granatomycin E bioactive polyketide [293] kendomycin bioactive polyketide [295] metenaticin A, B and C bioactive polyketide [293] Streptoverticillium cinnamoneum antibiotic HA 94 antimicrobial substance [296] Streptoverticillium mobaraense reports not found reports not found reports not found Syn. Rasamsonia emersonii reports not found reports not found 1-phenyl-3-methylpyrazolones oxidoreductase mediators [297] aryl tetral226in lignans bioactive compounds [298] podophyllotoxin bioactive compounds [298] Trametes versicolor funatrol D bioactive compound [299] isodrimenediol sesquiterpenes (anticancer) [299] tramspiroins sesquiterpenes (anticancer) [299] triterpenes bioactive compounds [300] Database on potential toxigenic capacities of microorganisms used for industrial production trichoderiol A, C [304] trichodimerol insecticide activity [302] Trichoderma harzianum 1,8-dihydroxy-3-methyl-anthraquinone antifungal [307] [308] [309] 1-hydroxy-3-methylanthraquinone antifungal [307] [308] [309] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. 2(5H)-furanone antifungal [308] 2,4-di-tert-butylphenol bioactive compound [310] 2,6,10-trimethylundeca-5,9-dienal bioactive compound [310] 2-phenylethanol bioactive compound [311] 6-pentyl-alpha-pyrone bioactive compound [312, 313] 6-methyl-1,3,8-trihydroxyanthraquinone antifungal [308] 6-n-pentyl-a-pyrone bioactive compound [311] 6-pentyl-2H-pyran-2-one antifungal [308] alpha-cubebene bioactive compound [310] alpha-curcumene bioactive compound [310] anthraquinones antifungal [314] azaphilone antifungal [307, 309] b-bisabolene bioactive compound [310] biformen (6CI) bioactive compound [310] butenolide antifungal [307, 309] chrysophanol antifungal [314, 315] cytochalasin analogs cytotoxic compound [316] Trichoderma harzianum decanolactone antifungal [308] emodin antifungal [314] Ref. ergosterol antifungal [308, 311, 317] fleephilone bioactive compound [318] gliotoxin bioactive compound [319] gliovirin bioactive compound [319, 320] harzianic acid siderophore [321] harzianolide anti-phytopathogen [307, 309, 322] harzianopyridone anti-phytopathogen [307] [308] [309] harziphilone bioactive compound [318] hexahydrofarnesol bioactive compound [310] indol acetic acid anti-phytopathogen [323] [324] [325] lignocerane bioactive compound [310] nerolidol bioactive compound [310] pachybasin, hydroxypachybasin anti-phytopathogen [314, 315] pentadecane bioactive compound [310] peptaibols bioactive compounds [326, 327] pristane bioactive compound [310] Trichoderma harzianum sitosterol antifungal [308] sorbicillin bioactive compound [311] stigmasterol antifungal [308] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. tandyukisins B-D (decalin derivative) cytotoxic [328] trichodenone A, B, C cytotoxic [329] trichodermin trichotecene toxin [319, 330] trichodermol (detected in hydrolysed crude extracts) trichotecene toxin [331] trichorzin peptaibol [332] tyrosol bioactive compound [311] verticillol bioactive compound [310] viridiofungin A anti-phytopathogen [333] Trichoderma koningii 6, 4-oxopentyl-2H-pyran-2-one antifungal [334] 6-pentyl-pyranone antifungal [334] 7-O-methylkoninginin D (polyketide derivative) antimicrobial [335] alpha-aminoisobutyric acid [336] amino alcohol (peptaibols) [336] decanolactone antifungal [334] koninginins A, D, E, F, L, M phospholipase A 2 inhibitors [335, 337, 338] stigmasterol antifungal [334] trichodermaketones A-D (polyketide derivatives) antimicrobial [335, 337] trichokonins (peptaibols) antimicrobial [339] [340] [341] Trichoderma longibranchiatum longibranchins (LGA I-V and LGB II-III) (peptaibols) biooactive compounds [342] [343] [344] [345] Database on potential toxigenic capacities of microorganisms used for industrial production Ref. trichobrachin A, C (peptaibols) biactive compounds [346] trichogin GA IV (peptaiboils) bioactive compound [347] trilongins BI-BIV (peptaibols) mitochondriotoxic [348] Trichoderma reesei fusarinine siderophore [349] kojic acid antibacterial activity [350] trichoderide A (cyclotetrapeotide) bioactive compound [351] trichodermatide A-D bioactive compound [352] trichodermin (trichothecene) mycotoxin [42] Trichoderma viride diacetoxyscirpenol mycotoxin [353] kojic acid antibacterial activity [350] lovastatin bioactive compound [122] trichovirins (2) Inhibition of virulence of Pseudomonas aeruginosa: A novel role of metronidazole against aerobic bacteria Spanish blue cheeses: Functional metabolites Identification of inhibitors of inducible nitric oxide synthase from microbial extracts Oxidative metabolism by P450 and function coupling to efflux systems: Modulation of mycotoxin toxicity The role of oxidative stress in citreoviridin-induced DNA damage in human liver-derived HepG2 cells Pouring Salt on a Wound: Pseudomonas aeruginosa Virulence Factors Alter Na+ and Cl-Flux in the Lung Antecedent acute kidney injury worsens subsequent endotoxin-induced lung inflammation in a two-hit mouse model Roquefortine C and mycophenolic acid in silages: Significance for animal health Combined effects of selected Penicillium mycotoxins on in vitro proliferation of porcine lymphocytes Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens Oxalic acid production by Aspergillus niger. Part II: Optimisation of fermentation with milk whey as carbon source The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha(1) protease inhibitor: Implications for the pathogenesis of cystic fibrosis lung disease Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin Evaluation of health aspects of kojic acid in food Final report of the safety assessment of Kojic acid as used in cosmetics Characterisation of the regulatory RNA RsmB from Pseudomonas aeruginosa PAO1 Morphological, molecular, and mycotoxigenic identification of dominant filamentous fungi from moldy civil cheese Real time quantitative expression study of a polyketide synthase gene related to ochratoxin a biosynthesis in Aspergillus niger Identification of Pseudomonas aeruginosa phenazines that kill Caenorhabditis elegans Endotoxin tolerance disrupts chromatin remodeling and NF-kappa B transactivation at the IL-1 beta promoter Lack of interaction between AFLR and AFLJ contributes to nonaflatoxigenicity of Aspergillus sojae Cyclopiazonic acid biosynthesis of Aspergillus flavus and Aspergillus oryzae Isolation, Purification, and Characterization of the PR Oxidase from Penicillium roqueforti A novel secondary metabolite relative to the degradation of PR toxin by Penicillium roqueforti Standardized chemical synthesis of Pseudomonas aeruginosa pyocyanin Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells Candida albicans Ethanol Stimulates Pseudomonas aeruginosa WspR-Controlled Biofilm Formation as Part of a Cyclic Relationship Involving Phenazines Marine Natural Products as Breast Cancer Resistance Protein Inhibitors Inactivation of pyocyanin synthesis genes has no effect on the virulence of Pseudomonas aeruginosa PAO1 toward the silkworm, Bombyx mori Inhibitory effects of 4-hydroxy-2,5-dimethyl-3(2H)-furanone (HDMF) on acyl-homoserine lactone-mediated virulence factor production and biofilm formation in Pseudomonas aeruginosa PAO1 Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains. Microbiology Effect of iron on cytolysin A expression in Salmonella enterica serovar Typhi Differential expression of two phenazine-producing loci mediated by deficiency of the global regulator rsmA in Data on the presence or absence of genes encoding essential proteins for ochratoxin and fumonisin biosynthesis in Aspergillus niger and Aspergillus welwitschiae Inhibition of autophagy by 3-methyladenine protects 1321N1 astrocytoma cells against pyocyanin-and 1-hydroxyphenazine-induced toxicity Paradoxical role of 3-methyladenine in pyocyanin-induced toxicity in 1321N1 astrocytoma and SH-SY5Y neuroblastoma cells Oxidative degradation and detoxification of mycotoxins using a novel source of ozone Stimulation of endothelial adhesion molecules by Bacteroides fragilis lipopolysaccharides from enterotoxigenic (ETBF) and non-enterotoxigenic (NTBF) strains Secondary Metabolites of Fusarium Venenatum Strains with Deletions in the Tri5 Gene Encoding Trichodiene Synthetase Cytotoxic Constituents of the Lichen Diploicia canescens 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions Overview on the Lipo-polysaccharide Endotoxin as Emergent Contaminant in Reclaimed Wastewater Identification of a cis-acting factor modulating the transcription of FUM1, a key fumonisin-biosynthetic gene in the fungal maize pathogen Fusarium verticillioides AhR sensing of bacterial pigments regulates antibacterial defence Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient Formation and disappearance of mycophenolic acid, patulin, penicillic acid and PR toxin in maize silage inoculated with Penicillium roqueforti Glutathione modulates the toxicity of, but is not a biologically relevant reductant for, the Pseudomonas aeruginosa redox toxin pyocyanin. Free Radical Biology and Medicine Presumptive tremorgenic mycotoxicosis in a dog in New Zealand, after eating mouldy walnuts A possible mechanism of gastrointestinal toxicity posed by mycophenolic acid HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: Database on potential toxigenic capacities of microorganisms used for industrial production therapeutic implications for Huntington's disease and Alzheimer's disease Andrastins A-D, Penicillium roqueforti Metabolites consistently produced in blue-mold-ripened cheese Review of secondary metabolites and mycotoxins from the Aspergillus niger group Production of metabolites from the Penicillium roqueforti complex Mycotoxins and other secondary metabolites produced in vitro by Penicillium paneum Frisvad and Penicillium roqueforti Thom isolated from baled grass silage in Ireland Redox eustress: roles for redox-active metabolites in bacterial signaling and behavior Toxicity of oxalic acid against adult Hyalomma lusitanicum ticks (Ixodida: Ixodidae) in laboratory conditions: LD50 Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells Multiplex PCR analysis of fumonisin biosynthetic genes in fumonisin-nonproducing Aspergillus niger and A. awamori strains Structure and mechanism of Pseudomonas aeruginosa PhzD, an isochorismatase from the phenazine biosynthetic pathway Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosa Strain-specific proteome responses of Pseudomonas aeruginosa to biofilm-associated growth and to calcium The fungal metabolite culmorin and related compounds Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88 Azithromycin Inhibits Expression of the GacA-Dependent Small RNAs RsmY and RsmZ in Pseudomonas aeruginosa Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels Biochemical method of oxalic acid production from beetmolasses Anti-inflammatory effects of Podophyllum hexandrum (RP-1) against lipopolysaccharides induced inflammation in mice Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin Pyocyanin induced in vitro oxidative damage and its toxicity level in human, fish and insect cell lines for its selective biological applications Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure The peptide chain release factor methyltransferase PrmC is essential for pathogenicity and environmental adaptation of Pseudomonas aeruginosa PA14 Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase A review of oxalate poisoning in domestic animals: tolerance and performance aspects Development of a simple and low cost microbioreactor for high-throughput bioprocessing Human targets of Pseudomonas aeruginosa pyocyanin In vitro cytotoxicity of fungi spoiling maize silage Alterations in protein kinase A signalling and cleft palate: a review Efficacy of aqueous medicinal plant extracts on growth and citrinin production by Penicillium citrinum isolated from rice grains The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer Nbutyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase The phzA2-G2 transcript exhibits direct RsmAmediated activation in Pseudomonas aeruginosa M18 Secalonic acid D; A cytotoxic constituent from marine lichen-derived fungus Gliocladium sp T31 Quenching of singlet oxygen by pyocyanin and related phenazines Photosensitized oxidation and inactivation of pyocyanin, a virulence factor of Pseudomonas aeruginosa Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide Synthetic studies of roquefortine C: synthesis of isoroquefortine C and a heterocycle Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa Oxalic acid production from lipids by a mutant of Aspergillus niger at different pH Inhibition of aflatoxin B1 mutagenicity by cyclopiazonic acid in the presence of human liver preparations Influence of milk whey Evaluation of different carbon and nitrogen sources in production of rhamnolipids by a strain of Pseudomonas aeruginosa. Applied biochemistry and biotechnology A Pseudomonas aeruginosa EF-hand protein, EfhP (PA4107), modulates stress responses and virulence at high calcium concentration Expression of a gfp gene in Penicillium nordicum under control of the promoter of the ochratoxin A polyketide synthase gene Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity Pseudomonas aeruginosa aerobic fatty acid desaturase DesB is important for virulence factor production Functional expression of the Aspergillus flavus PKS-NRPS hybrid CpaA involved in the biosynthesis of cyclopiazonic acid Current and Future Experimental Strategies for Structural Analysis of Trichothecene Mycotoxins-A Prospectus Enhanced bioelectricity generation by improving pyocyanin production and membrane permeability through sophorolipid addition in Pseudomonas aeruginosa-inoculated microbial fuel cells Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes Quorum quenching by an Nacyl-homoserine lactone acylase from Pseudomonas aeruginosa PAO1 Up-regulating pyocyanin production by amino acid addition for early electrochemical identification of Pseudomonas aeruginosa From mice to man: the preclinical history of mycophenolate mofetil Database on potential toxigenic capacities of microorganisms used for industrial production seasonal and avian influenza viruses affecting humans Identification of a novel polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) gene required for the biosynthesis of cyclopiazonic acid in Aspergillus oryzae Therapeutic effects of three trichothecenes in the silkworm infection assay with Candida albicans Potassium and sodium transporters of Pseudomonas aeruginosa regulate virulence to barley Pulmonary aspergilloma with renal oxalosis: Fatal effect at a distance The Pseudomonas aeruginosa oxidative stress regulator OxyR influences production of pyocyanin and rhamnolipids: Protective role of pyocyanin. Microbiology Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells Citreoviridin-induced rat myocardial damage under combined selenium and protein deficiency Anomaly detection in host signaling pathways for the early prognosis of acute infection Bioactive metabolites from Phoma species, an endophytic fungus from the Chinese medicinal plant Arisaema erubescens Engineering PQS Biosynthesis Pathway for Enhancement of Bioelectricity Production in Pseudomonas aeruginosa Microbial Fuel Cells Genomic features and regulation of phenazine biosynthesis in the rhizosphere strain Pseudomonas aeruginosa M18 Pseudomonas aeruginosa Pyocyanin Activates NRF2-ARE-Mediated Transcriptional Response via the ROS-EGFR-PI3K-AKT/MEK-ERK MAP Kinase Signaling in Pulmonary Epithelial Cells Acute renal failure and metabolic acidosis due to oxalic acid intoxication: a case report Pseudomonas toxin pyocyanin triggers autophagy: Implications for pathoadaptive mutations Tremorgenic mycotoxin intoxication with penitrem A and roquefortine in two dogs Induction of RelB participates in endotoxin tolerance Biochemical tests of rat cardiac injury induced by citreoviridin toxin in rats with joint deficiency of selenium and protein In vitro evidence for mycophenolic aciddose-related cytotoxicity in human retinal cells Secalonic acid A reduced colchicine cytotoxicity through suppression of JNK, p38 MAPKs and calcium influx Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP )-induced cell death via the mitochondrial apoptotic pathway Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of GSK-3 beta/betacatenin/c-Myc pathway Effect of glutathione on pyocyanin production in Pseudomonas aeruginosa Functional characterization of the gene PA2384 in large-scale gene regulation in response to iron starvation in Pseudomonas aeruginosa Mycophenolic acid in rheumatology: mechanisms of action and severe adverse events Aculeatusquinones A-D, novel metabolites from the marine-derived fungus Aspergillus aculeatus A new steroid with long crossconjugation structure from the marine-derived fungus Aspergillus aculeatus Asperaculanes A and B, two sesquiterpenoids from the fungus Aspergillus aculeatus Bioactive alkaloids of fungal origin Asperparaline A, a new paralytic alkaloid rom Aspergillus japonicus JV-23 A fungal metabolite Asperparaline A strongly and selectively blocks insect nicotinic acetylcholine receptors: the first report on the mode of action New paralytic alkaloids, asperparalines A, B and C, from Aspergillus japonicus JV-23 The important ergot alkaloid intermediate chanoclavine-I produced in the yeast Saccharomyces cerevisiae by the combined action of EasC and EasE from Aspergillus japonicus Aspergillus uvarum sp. nov., an uniseriate black Aspergillus species isolated from grapes in Europe Neoxaline, a new alkaloid produced by Aspergillus japonicus. Production, isolation and properties Efficient total synthesis of novel bioactive microbial metabolites Survey of Philippine coffee beans for the presence of ochratoxigenic fungi Detection of VM55599 and preparaherquamide from Aspergillus japonicus and Penicillium fellutanum: biosynthetic implications Allelopathic effects of secalonic acid F produced by Aspergillus japonicus on Zea mays Database on potential toxigenic capacities of microorganisms used for industrial production 15 Allelopathy of Aspergillus japonicus on crops Mycotoxin production on rice Aspyrone, a nematicidal compound isolated from the fungus, Aspergillus melleus Isolation and insecticidal activity of mellamide from Aspergillus melleus Antimicrobial and antioxidant activities of endophytes from Tabebuia argentea and identification of anticancer agent (lapachol) Strain improvement of Aspergillus niger for the enhanced production of asperenone Structure and total synthesis of aspernigerin: a novel cytotoxic endophyte metabolite Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus niger SCSIO Jcsw6F30 Proteome analysis of Aspergillus niger: lactate added in starch-containing medium can increase production of the mycotoxin fumonisin B2 by modifying acetyl-CoA metabolism Occurrence of naphthogamma-pyrones-and ochratoxin A-producing fungi in French grapes and characterization of new naphtho-gamma-pyrone polyketide (aurasperone G) isolated from Aspergillus niger C-433 Structures and absolute configuration of three α-pyrones from an endophytic fungus Aspergillus niger Genome mining and functional genomics for siderophore production in Aspergillus niger Reliable and simple detection of ochratoxin and fumonisin production in black Aspergillus Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88 Database on potential toxigenic capacities of microorganisms used for industrial production 29 Aspergillus spp. and their secondary metabolite production in grape berries from Slovakia Influence of light on growth, conidiation and the mutual regulation of fumonisin B2 and ochratoxin A biosynthesis by Aspergillus niger Aspergillus niger contains the cryptic phylogenetic species A. awamori Multiplex PCR analysis of fumonisin biosynthetic genes in fumonisin-nonproducing Aspergillus niger and A. awamori strains Prospecting for the incidence of genes involved in ochratoxin and fumonisin biosynthesis in Brazilian strains of Aspergillus niger and Aspergillus welwitschiae Review of secondary metabolites and mycotoxins from the Aspergillus niger group Identification of a cisacting factor modulating the transcription of FUM1, a key fumonisin-biosynthetic gene in the fungal maize pathogen Fusarium verticillioides Fumonisin B(2) production by Aspergillus niger from grapes and natural occurrence in must Oxygenated hexylitaconates from a marine sponge-derived fungus Penicillium sp Toxigenic fungi isolated from dried fruits: Detection of Aspergillus toxins in Saudi Arabia Mycotoxins from mould infested building materials Nigerasperones A approximately C, new monomeric and dimeric naphtho-gamma-pyrones from a marine alga-derived endophytic fungus Aspergillus niger EN-13 Production of toxic metabolites in Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei: justification of mycotoxin testing in food grade enzyme Database on potential toxigenic capacities of microorganisms used for industrial production preparations derived from the three fungi Molecular biological researches of Kuro-Koji molds, their classification and safety Mycelial growth and ochratoxin A production by Aspergillus section Nigri on simulated grape medium in modified atmospheres Mycotoxin-producing and other fungi isolated from grapes for wine production, with particular emphasis on ochratoxin A Occurrence of pathogenic fungal species in Tunisian vineyards Ochratoxigenic black species of Aspergilli in grape fruits of northern Italy identified by an improved PCR-RFLP procedure Ochratoxin A production by Aspergillus niger: effect of water activity and a biopreserver formulated with Lactobacillus plantarum CRL 778 Optimal fresh: The fruit, vegetable and fresh produce storage expert system OTA-producing fungi in foodstuffs: A review Real time quantitative expression study of a polyketide synthase gene related to ochratoxin a biosynthesis in Aspergillus niger Effect of gentian violet on the growth of the N and T RFLP types of the Aspergillus niger aggregate A survey of ochratoxin a in wheat and barley in India Oxaloacetate hydrolase, the C-C bond lyase of oxalate secreting fungi Identification of fungal oxaloacetate hydrolyase within the isocitrate lyase/PEP mutase enzyme superfamily using a sequence marker-based method Impact of macro-elements on oxalic acid biosynthesis process by Aspergillus niger with glycerol Characterization of four new antifungal yanuthones from Aspergillus niger Comparative chemistry of Aspergillus oryzae (RIB40) and A. flavus Genetic safeguard against mycotoxin cyclopiazonic acid production in Aspergillus oryzae Mycotoxin production by fungi isolated from stored grains Mycotoxin production in wheat grains by different Aspergilli in relation to different relative humidities and storage periods Biosynthesis of the halogenated mycotoxin Aspirochlorine in Koji mold involves a cryptic amino acid conversion Drimane sesquiterpenoids from the Aspergillus oryzae QXPC-4 A new diketopiperazine alkaloid from Aspergillus oryzae A review of studies and measures to improve the mycotoxicological safety of traditional Japanese mold-fermented foods An evaluation of aflatoxin and cyclopiazonic acid production in Aspergillus oryzae Cyclopiazonic acid biosynthesis of Aspergillus flavus and Aspergillus oryzae Identification of a novel polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) gene required for the biosynthesis of cyclopiazonic acid in Aspergillus oryzae Database on potential toxigenic capacities of microorganisms used for industrial production 70 Aspergillus oryzae NRRL 35191 from coffee, a non-toxigenic endophyte with the ability to synthesize kojic acid Antiviral and cytotoxic isocoumarin derivatives from an endophytic fungus Aspergillus oryzae Speradines B-E, four novel tetracyclic oxindole alkaloids from the marine-derived fungus Aspergillus oryzae Speradines F-H, three new oxindole alkaloids from the marine-derived fungus Aspergillus oryzae Identification and toxigenic potential of the industrially important fungi, Aspergillus oryzae and Aspergillus sojae Glyceollins inhibit plateletderived growth factor-mediated human arterial smooth muscle cell proliferation and migration Anti-septic effects of glyceollins in HMGB1-induced inflammatory responses in vitro and in vivo Tryptanthrins and other tryptophan-derived agonists of the dioxin receptor Tryptanthrins: A novel class of agonists of the aryl hydrocarbon receptor Characterization of metabolites from cultures of Isolation and identification of secondary metabolites from fungus Chaetomium gracile and their antimicrobial activities D-glucans from the cell wall of Cryphonectria parasitica (Murr.) Barr strain 263 A Hydrophobin of the chestnut blight fungus, Cryphonectria parasitica, is required for stromal pustule eruption The mycovirus CHV1 disrupts secretion of a developmentally regulated protein in Cryphonectria parasitica Database on potential toxigenic capacities of microorganisms used for industrial production 84 Cryphonectric acid and other minor metabolites from a hypovirulent strain of Cryphonectria parasitica Identification of a polyketide synthase gene in the synthesis of phleichrome of the phytopathogenic fungus Cladosporium phlei Studies on the non-pathogenicity of Chryseobacterium proteolyticum and on the safety of the enzyme: Protein-glutaminase Curli fibers are required for development of biofilm architecture in Escherichia coli K-12 and enhance bacterial adherence to human uroepithelial cells Molecular analysis of cytolysin A (ClyA) in pathogenic Escherichia coli strains Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli Redefining the requisite lipopolysaccharide structure in Escherichia coli Characterization of the avian pathogenic Escherichia coli hemagglutinin Tsh, a member of the immunoglobulin A proteasetype family of autotransporters Secondary metabolites of Fusarium venenatum strains with deletions in the Tri5 gene encoding trichodiene synthetase Engineered production of fungal anticancer cyclooligomer depsipeptides in Saccharomyces cerevisiae Screenig of bioactive compounds by GC-Ms from Fusarium venenatum Deletion of the trichodiene synthase gene of Fusarium venenatum: two systems for repeated gene deletions Fusarin C biosynthesis in Fusarium moniliforme and Fusarium venenatum Taguchi's experimental design for optimizing the production of novel thermostable polypeptide antibiotic from Geobacillus pallidus SAT4 Auxin production by Klebsiella planticola strain TSKhA-91 and its effect of development of cucumber (Cucumis sativus L.) seeds. Mikrobiologiia 3-Hydroxypropionaldehyde guided glycerol feeding strategy in aerobic 1,3-propanediol production by Klebsiella pneumoniae A gene, uge, is essential for Klebsiella pneumoniae virulence Detection of 3-nitropropionic acid and cytotoxicity in Mucor circinelloides Liquid chromatography-tandem mass spectrometry characterization of five new leucinostatins produced by Paecilomyces lilacinus. CG-189 Testing the nematophagous biological control strain Paecilomyces lilacinus 251 for paecilotoxin production Bacterial spot and early blight biocontrol by epiphytic bacteria in tomato plants Selection of rhizobacteria able to produce metabolites active against Meloidogyne exigua Sporulation of Penicillium camemberti in submerged batch culture Secondary metabolites of halotolerant fungus Penicillium chrysogenum HK14-01 from the Yellow River Delta area Chrysogenamide A from an endophytic fungus associated with Cistanche deserticola and its neuroprotective effect on SH-SY5Y cells Secondary metabolites from a marine-derived endophytic fungus Penicillium chrysogenum QEN-24S Biosynthesis of bromoroquefortines in a high saline medium by Penicillium chrysogenum Triazoles and other N-containing metabolites from the marine-derived endophytic fungus Penicillium chrysogenum EN-118 Rare C25 steroids produced by Penicillium chrysogenum P1X, a fungal endophyte of Huperzia serrata The first sorbicillinoid alkaloids, the antileukemic sorbicillactones A and B, from a spongederived Penicillium chrysogenum strain BMS-182123, a fungal metabolite that inhibits the production of TNF-alpha by macrophages and monocytes Batch culture fermentation of Penicillium chrysogenum and a report on the isolation, purification, identification and antibiotic activity of citrinin Studies on toxigenic fungi in roasted foodstuff (salted seed) and halotolerant activity of emodin-producing Aspergillus wentii A preliminary survey on the occurrence of mycotoxigenic fungi and mycotoxins contaminating red rice at consumer level in Selangor Conidiogenones H and I, two new diterpenes of Cyclopiane class from a marine-derived endophytic fungus Penicillium chrysogenum QEN-24S Estimation of fungal contamination and mycotoxin production at workplaces in composting plants, tanneries, archives and libraries Fungi associated with rocks of the Atacama desert: taxonomy, distribution, diversity, ecology and bioprospection for bioactive compounds Exposure assessment of lovastatin in Pu-erh tea Toxins from strains of Penicillium chrysogenum isolated from buildings and other sources Isolation of mycotoxin-producing fungi from fishes growing in aquacultures Penicisteroids A and B, antifungal and cytotoxic polyoxygenated steroids from the marine alga-derived endophytic fungus Penicillium chrysogenum QEN-24S Penicitols A-C and penixanacid A from the mangrove-derived Penicillium chrysogenum HDN11-24 Penimethavone A, a flavone from a gorgonian-derived fungus Penicillium chrysogenum Penicillin productivity and glutathionedependent detoxification of phenylacetic and phenoxyacetic acids in Penicillium chrysogenum Molecular characterization of the PR-toxin gene cluster in Penicillium roqueforti and Penicillium chrysogenum: cross talk of secondary metabolite pathways A study of the toxicity of moulds isolated from dwellings Microscopic fungi recovered from honey and their toxinogenity Microfungi and mycotoxins of grapes from eastern Slovak wine region Diversity and pharmaceutical screening of fungi from benthic mats of Antarctic lakes Penicillium strains isolated from Slovak grape berries taxonomy assessment by secondary metabolite profile Alkaloids and polyketides from Penicillium citrinum, an endophyte isolated from the Moroccan plant Ceratonia siliqua Bioactive polyketides and alkaloids from Penicillium citrinum Toxic activity of Penicillium citrinum metabolites on Mus musculus mice Database on potential toxigenic capacities of microorganisms used for industrial production 139 betel) on growth and citrinin production from toxigenic Penicillium citrinum Conditions that regulate the growth of moulds inoculated into bottled mineral water Citrinin production and stability in cheese Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor Producers and important dietary sources of ochratoxin A and citrinin Study of toxigenic properties of mycelium fungi--citrinin producents, isolated from foods Citrinin derivatives from the marine-derived fungus Penicillium citrinum Structural and ultrastructural alterations in BALB/c mice: effects of Penicillium citrinum metabolites Secondary metabolites characteristic of Penicillium citrinum, Penicillium steckii and related species The influence of medium composition on alkaloid biosynthesis by Penicillium citrinum Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs cDNA cloning and immunological characterization of a newly identified enolase allergen from Penicillium citrinum and Aspergillus fumigatus The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model Database on potential toxigenic capacities of microorganisms used for industrial production 153 Complementary DNA cloning and immunologic characterization of a new Penicillium citrinum allergen (Pen c 3) Secretome analysis of novel IgE-binding proteins from Penicillium citrinum Pen c 1, a novel enzymic allergen protein from Penicillium citrinum. Purification, characterization, cloning and expression Identification and expression of Pen c 2, a novel allergen from Penicillium citrinum Molecular and immunological characterization and IgE epitope mapping of Pen n 18, a major allergen of Penicillium notatum A novel citrinin derivative from the marine-source fungus Penicillium citrinum Perinadine A, a novel tetracyclic alkaloid from marine-derived fungus Penicillium citrinum Quinolactacide, a new quinolone insecticide from Penicillium citrinum Thom F 1539 Structure determination of two unusual C25 steroids with bicyclo Cyclopenicillone, a unique cyclopentenone from the cultures of Penicillium decumbens Fungal melanin inhibitor and related compounds from Penicillium decumbens In vitro inhibition of Helicobacter pylori by micromycetes Chrodrimanins I and J from the antarctic moss-derived fungus Penicillium funiculosum GWT2-24 Mycotoxins and non-fungicidal control of corn grain rotting fungi Database on potential toxigenic capacities of microorganisms used for industrial production 167 Endophytic Penicillium funiculosum LHL06 secretes gibberellin that reprograms Glycine max L. growth during copper stress Factors affecting the production of mitorubrinic acid by Penicillium funiculosum OR-1--a mixture of esters of glyceric acid produced by Penicillium funiculosum and its antitrypsin activity Synthesis and evaluation of dioleoyl glyceric acids showing antitrypsin activity Effectiveness of Allium sativum in controlling sorghum grain molding fungi Induced production of new diterpenoids in the fungus Penicillium funiculosum A comparative study of siderophore production by fungi from marine and terrestrial habitats Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells Liposome-based formulations for the antibiotic nonapeptide Leucinostatin A: Fourier transform infrared spectroscopy characterization and in vivo toxicologic study In vitro evaluation of the phytotoxin production ability by fungi with antagonic properties to nematodes Bioactive azaphilones from the fungus Penicillium multicolor CM01 New brominatedand halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor Sclerotiorin and Isochromophilone IV: Inhibitors of Grb2-Shc Interaction, Isolated from Penicillium multicolor F1753 The influence of salt (NaCl) on ochratoxin A biosynthetic genes, growth and ochratoxin A production by three strains of Database on potential toxigenic capacities of microorganisms used for industrial production Penicillium nordicum on a dry-cured ham-based medium Influence of abiotic parameters on ochratoxin A production by a Penicillium nordicum strain in dry-cured meat model systems Analysis of differentially-expressed ochratoxin A biosynthesis genes of Penicillium nordicum A new in vitro method to detect growth and ochratoxin A-producing ability of multiple fungal species commonly found in food commodities Gene expression as an indication for ochratoxin A biosynthesis in Penicillium nordicum The application of transcriptomics to understand the ecological reasons of ochratoxin A biosynthesis by Penicillium nordicum on sodium chloride rich dry cured foods Influence of carbon and nitrogen sources on ochratoxin A production by two species of Penicillium isolated from poultry feeds. Archives of Phytopathology and Plant Protection Culture media and factors influencing ochratoxin A production by two species of Penicillium isolated from poultry feeds Evaluation of different methods to prevent Penicillium nordicum growth on and ochratoxin A production in country-style sausages Presence of ochratoxin A on the surface of dry-cured Iberian ham after initial fungal growth in the drying stage Proteolytic activity, mycotoxins and andrastin A in Penicillium roqueforti strains isolated from Cabrales, Valdeón and Bejes-Tresviso local varieties of blue-veined cheeses Andrastins A-D, Penicillium roqueforti metabolites consistently produced in blue-mold-ripened cheese Database on potential toxigenic capacities of microorganisms used for industrial production 195 Mycotoxins and other secondary metabolites produced in vitro by Penicillium paneum Frisvad and Penicillium roqueforti Thom isolated from baled grass silage in Ireland Volatile sesquiterpene hydrocarbons characteristic for Penicillium roqueforti strains producing PR toxin Penicillium roqueforti: a multifunctional cell factory of high value-added molecules Toxin producing species of Penicillium and the development of mycotoxins in must and homemade wine Production of metabolites from the Penicillium roqueforti complex Review on mycotoxin issues in ruminants: occurrence in forages, effects of mycotoxin ingestion on health status and animal performance and practical strategies to counteract their negative effects Immobilization technique for enhanced production of the immunosuppressant mycophenolic acid by ultraviolet and gamma-irradiated Penicillium roqueforti Optimization of submerged fermentation conditions for immunosuppressant mycophenolic acid production by Penicillium roqueforti isolated from blue-molded cheeses: enhanced production by ultraviolet and gamma irradiation Mycophenolic acid in silage Neurotoxicity of mycotoxins produced in vitro by Penicillium roqueforti isolated from maize and grass silage Formation and disappearance of mycophenolic acid, patulin, penicillic acid and PR toxin in maize silage inoculated with Penicillium roqueforti Secondary metabolites from Penicillium roqueforti, a starter for the production of Gorgonzola cheese Occurrence of roquefortine C, mycophenolic acid and aflatoxin M1 mycotoxins in blue-veined cheeses Mycotoxin production capability of Penicillium roqueforti in strains isolated from mould-ripened traditional Turkish civil cheese Roquefortine C occurrence in blue cheese Influence of octanoic acid addition to medium on some volatile compounds and PR-toxin biosynthesis by Penicillium roqueforti Isolation of moulds capable of producing mycotoxins from blue mouldy Tulum cheeses produced in Turkey Growth and mycotoxin production by fungi in atmospheres containing 80% carbon dioxide and 20% oxygen Growth and mycotoxin production by food spoilage fungi under high carbon dioxide and low oxygen atmospheres Influence of intraspecific variability and abiotic factors on mycotoxin production in Penicillium roqueforti Occurrence of roquefortine in silage -toxicological relevance to sheep Effect of a heterotrimeric G protein alpha subunit on conidia germination, stress response, and roquefortine C production in Penicillium roqueforti Isolation and metabolite production by Penicillium roqueforti, P. paneum and P. crustosum isolated in Canada Incidence of Penicillium roqueforti and roquefortine C in silages +)-Cyclopenol, a new naturally occurring 7-membered 2,5-dioxopiperazine alkaloid from the fungus Penicillium sclerotiorum endogenous with the Chinese mangrove Bruguiera gymnorrhiza Antimicrobial properties of sclerotiorin, isochromophilone VI and pencolide, metabolites from a Brazilian cerrado isolate of Penicillium sclerotiorum van Beyma Database on potential toxigenic capacities of microorganisms used for industrial production 222 Improved production of pharmacologically-active sclerotiorin by Penicillium sclerotiorum Electrochemistry provides a simple way to monitor Pseudomonas aeruginosa metabolites MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline) Purification, crystallization and preliminary X-ray diffraction analysis of Cif, a virulence factor secreted by Pseudomonas aeruginosa A Pseudomonas aeruginosa toxin (Cif) reduces plasma membrane CFTR by inactivating the deubiquitinating enzyme USP10 Effects of allicin on the formation of Pseudomonas aeruginosa biofilm and the production of quorum-sensing controlled virulence factors Pseudomonas aeruginosa toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function GPR107, a G-protein-coupled receptor essential for intoxication by Pseudomonas aeruginosa exotoxin A, localizes to the Golgi and is cleaved by furin A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar Database on potential toxigenic capacities of microorganisms used for industrial production fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin The Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid inhibits growth and induces encystment in Acanthamoeba castellanii Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses Engineering the central biosynthetic and secondary metabolic pathways of Pseudomonas aeruginosa strain PA1201 to improve phenazine-1-carboxylic acid production Generation of reactive oxygen species mediated by 1-hydroxyphenazine, a virulence factor of Pseudomonas aeruginosa Identification of Pseudomonas aeruginosa phenazines that kill Caenorhabditis elegans Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation Effect of glutathione on pyocyanin production in Pseudomonas aeruginosa Gene PA2449 is essential for glycine metabolism and pyocyanin biosynthesis in Pseudomonas aeruginosa PAO1 Inactivation of the potent Pseudomonas aeruginosa cytotoxin pyocyanin by airway peroxidases and nitrite Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence Production and purification of pyocin from a soil associated Pseudomonas aeruginosa strain SA 188 Pyocyanin induced in vitro oxidative damage and its toxicity level in human, fish and insect cell lines for its selective biological applications Pyocyanin-induced mucin production is associated with redox modification of FOXA2 Pyocyanin production by Pseudomonas aeruginosa confers resistance to ionic silver Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophilmediated host defenses in vivo Pyocyanin stimulates quorum sensingmediated tolerance to oxidative stress and increases persister cell populations in Acinetobacter baumannii Pyocyanin, a virulence factor produced by Pseudomonas aeruginosa, alters root development through reactive oxygen species and ethylene signaling in Arabidopsis Pyocyanin: production, applications, challenges and new insights Pyocycanin, a contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung Pseudomonas aeruginosa pyocyanin with reduced glutathione Transcriptional activation of pyoluteorin operon mediated by the LysR-type regulator PltR bound at a 22 bp lys box in Pseudomonas aeruginosa M18 1.2 Å resolution crystal structure of the periplasmic aminotransferase PvdN from Pseudomonas aeruginosa Interactions between an anti-sigma protein and two sigma factors that regulate the pyoverdine signaling pathway in Pseudomonas aeruginosa Endotoxinlike properties of a rhamnolipid exotoxin from Burkholderia (Pseudomonas) plantarii: immune cell stimulation and biophysical characterization A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria TypA is involved in virulence, antimicrobial resistance and biofilm formation in Pseudomonas aeruginosa Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells KSD-815 isolated from nuruk induces apoptosis in prostate cancer LNCaP cells Cytotoxic and anti-inflammatory activities of lipids from the nuruk (Rhizopus oryzae KSD-815) Purification, cloning and immuno-biochemical characterization of a fungal aspartic protease allergen Rhi o 1 from the airborne mold Rhizopus oryzae Activation and identification of five clusters for secondary metabolites in Streptomyces albus J1074 Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment Combinatorial biosynthesis of antitumor indolocarbazole compounds Polycyclic tetrahydroxanthones from Streptomyces chrestomyceticus BCC 24770 Ironmediated synthesis of carazostatin, a free radical scavenger from Streptomyces chromofuscus, and O-methylcarazostatin Enhancement of herboxidiene production in Streptomyces chromofuscus ATCC 49982 2-Demethylmonensins A and B. Novel minor congeners of monensins from Streptomyces cinnamonensis Arcyriaflavin E, a new cytotoxic indolocarbazole alkaloid isolated by combined-culture of mycolic acid-containing bacteria and Streptomyces cinnamoneus NBRC 13823 A gene cluster for prenylated naphthoquinone and prenylated phenazine biosynthesis in Streptomyces cinnamonensis DSM 1042 Biosynthesis of the isoprenoid moieties of furanonaphthoquinone I and endophenazine A in Streptomyces cinnamonensis DSM 1042 Biosynthesis of colabomycin E, a new manumycin-family metabolite, involves an unusual chain-length factor Development of a new medium containing date syrup for production of bleomycin by Streptomyces mobaraensis ATCC 15003 using response surface methodology Mining of the pyrrolamide antibiotics analogs in Streptomyces netropsis reveals the amidohydrolase-dependent "iterative strategy" underlying the pyrrole polymerization Natural combinatorial biosynthesis involving two clusters for the synthesis of three pyrrolamides in Streptomyces netropsis Identification of secondary metabolites from Streptomyces violaceoruber TU22 by means of on-flow LC-NMR and LC-DAD-MS Identification of four genes from the granaticin biosynthetic gene cluster of Streptomyces violaceoruber Tü22 involved in the biosynthesis of Lrhodinose A type I/type III polyketide synthase hybrid biosynthetic pathway for the structurally unique ansa compound kendomycin A novel Streptoverticillium cinnamonium var scleroticum producing a polyene antibiotic Phenylpyrazolones, novel oxidoreductase redox mediators for degradation of xenobiotics The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans Four new spiroaxane sesquiterpenes and one new rosenonolactone derivative from cultures of Basidiomycete Trametes versicolor Qualitative analysis of an ethanolic extract from Trametes versicolor and biological screening against Leishmania amazonensis Trichocitrin, a new fusicoccane diterpene from the marine brown alga-endophytic fungus Trichoderma citrinoviride Bisorbicillinoids produced by the fungus Trichoderma citrinoviride affect feeding preference of the aphid Schizaphis graminum Citrantifidiene and citrantifidiol: bioactive metabolites produced by Trichoderma citrinoviride with potential antifeedant activity toward aphids Novel cytotoxic metabolites from the marinederived fungus Trichoderma citrinoviride Occurrence and characterization of peptaibols from Trichoderma citrinoviride, an endophytic fungus of cork oak, using electrospray ionization quadrupole time-of-flight mass spectrometry Antimicrobial activity of substances produced by Trichoderma citrinoviride strain VKPM F-1228: optimization of cultivation and assessment of spectrum of individual peptaibols Major secondary metabolites produced by two commercial Trichoderma strains active against different phytopathogens Comparative evaluation of two Trichoderma harzianum strains for major secondary metabolite production and antifungal activity Factors affecting the production of Trichoderma harzianum secondary metabolites during the interaction with different plant pathogens Fusarium oxysporum induces the production of proteins and volatile organic compounds by Trichoderma harzianum T-E5 Bioactive metabolites from Trichoderma harzianum and Trichoderma longibrachiatum The potential application of aqueous two-phase systems for in situ recovery of 6-pentyl-infinitypyrone produced by Trichoderma harzianum Trichoderma harzianum and its metabolite 6-pentyl-alpha-pyrone suppress fusaric acid produced by Fusarium moniliforme Database on potential toxigenic capacities of microorganisms used for industrial production 314 Study on the anthraquinones separated from the cultivation of Trichoderma harzianum strain Th-R16 and their biological activity The evaluation of metabolites as chrysophanol and pachybasin produced from Trichoderma harzianum strain ETS 323 on plant pathogens and vegetable crops A new cytotoxic cytochalasin from the endophytic fungus Trichoderma harzianum Cloning and characterization of the erg1 gene of Trichoderma harzianum: effect of the erg1 silencing on ergosterol biosynthesis and resistance to terbinafine Harziphilone and fleephilone, two new HIV REV/RRE binding inhibitors produced by Trichoderma harzianum Biocontrol potential of salinity tolerant mutants of Trichoderma harzianum against Fusarium oxysporum Inhibition of inducible tumor necrosis factoralpha expression by the fungal epipolythiodiketopiperazine gliovirin Harzianic acid: a novel siderophore from Trichoderma harzianum Harzianolide, a novel plant growth regulator and systemic resistance elicitor from Trichoderma harzianum Biopotential of some Trichoderma spp. against cotton root rot pathogens and profiles of some of their metabolites Evaluation of plant growth promoting activities of microbial strains and their effect on growth and yield of chickpea Putative Trichoderma harzianum mutant promotes cucumber growth by enhanced production of indole acetic acid and plant colonization Biological effects of Trichoderma harzianum peptaibols on mammalian cells Database on potential toxigenic capacities of microorganisms used for industrial production 327 Peptaibol, secondary-metabolite, and hydrophobin pattern of commercial biocontrol agents formulated with species of the Trichoderma harzianum complex Determination of the chemical structures of tandyukisins B-D, isolated from a marine spongederived fungus Total Syntheses of Trichodenones AC Antimycotic compounds from the plant pathogen Rhizoctonia solani and its antagonist Trichoderma harzianum Fast methods for screening of trichothecenes in fungal cultures using GC-MS/MS Directed biosynthesis of peptaibol antibiotics in two Trichoderma strains. II. Structure elucidation Detection of viridiofungin A and other antifungal metabolites excreted by Trichoderma harzianum active against different plant pathogens Isolation, characterisation of major secondary metabolites of the Himalayan Trichoderma koningii and their antifungal activity Trichodermaketones A-D and 7-O-methylkoninginin D from the marine fungus Trichoderma koningii Combined use of LC/MS and a biological test for rapid identification of marine mycotoxins produced by Trichoderma koningii Koninginins L and M, two polyketides from Trichoderma koningii 8662 A2 inhibitors from endophytic fungus Trichoderma koningii Studies on metabolites of mycoparasitic fungi. V. Ion-spray ionization mass spectrometric analysis of trichokonin-II, a peptaibol mixture obtained from the culture broth of Trichoderma koningii Broadspectrum antimicrobial activity and high stability of Trichokonins from Trichoderma koningii SMF2 against plant pathogens Solid-state fermentation for Trichokonins production from Trichoderma koningii SMF2 and preparative purification of Trichokonin VI by a simple protocol The ion-channel activity of longibrachins LGA I and LGB II: effects of Pro-2/Ala and Gln-18/Glu substitutions on the alamethicin voltage-gated membrane channels Sequences and antimycoplasmic properties of longibrachins LGB II and LGB III, two novel 20-residue peptaibols from Trichoderma longibrachiatum Enhancement of domoic acid neurotoxicity on Diptera larvae bioassay by marine fungal metabolites Identification and biological activities of long-chain peptaibols produced by a marine-derived strain of Trichoderma longibrachiatum New Trichobrachins, 11-residue peptaibols from a marine strain of Trichoderma longibrachiatum The peculiar N-and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity 20-Residue and 11-residue peptaibols from the fungus Trichoderma longibrachiatum are synergistic in forming Na+/K+ -permeable channels and adverse action towards mammalian cells Isotope-assisted screening for iron-containing metabolites reveals a high degree of diversity among known and unknown siderophores produced by Trichoderma spp Screening and production of antibacterial compound from Trichoderma spp. against human-pathogenic bacteria A new cyclotetrapeptide from marine fungus Trichoderma reesei Trichodermatides A-D, novel polyketides from the marine-derived fungus Trichoderma reesei Distribution and mycotoxin-producing ability of some fungal isolates from the air Database on potential toxigenic capacities of microorganisms used for industrial production 354 Production of γ-decalactone by Yarrowia lipolytica: insights into experimental conditions and operating mode optimization (C(OC)=O)C1=O)=O RF-00004573-PAR Aristolochene -Yes (4S,4aR,6S)-4 RF-00004548-PAR Asperparaline A -Yes (1R ,5aR ,7R ,8aR ,9aS )-1,1 )O2)OC)C)O)(C)O RF-00004574-PAR Culmorin RF-00004549-PAR Fusarin C -Yes methyl (2E,3E,5E,7E,9E RF-00004575-PAR Isofumigaclavine A -Yes [(6aR,9S,10R)-7,9-dimethyl-6,6a,8,9 RF-00004554-PAR Secalonic acid -Yes methyl (3R,4S,4aS)-7-[(5S,6R,10aS)-1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-2-yl C)O)C(=O)OC)O)O[C@@]2([C@H]1O)C(=O) OC)O RF-00004568-PAR Trichodermin -Yes (4β,12R )-12,13-epoxytrichothec-9 RF-00004570-PAR Xanthomegnin -Yes (3R,3'R)-10,10'-Dihydroxy-7 =O)O1)O)C(=O)C(=C(C3 =O)OC)C4=C(C(=O)c5cc6c(c(c5C4=O)O)C(=O)O[C @@H NAD: Non-available data 16S rRNA sequence analyses: Housekeeping genes and MLSA. NAD NAD NAD NAD No Taxonomy data available/ Not validated , DNA-DNA hybridization AB100738 16S rRNA gene DNA-DNA hybridization, LFRFA, RAPD-PCR assays, 16S rRNA, 23S rRNA, 5S rRNA genes, RFLPs of rRNA AJ621602 16S rRNA Current taxonomy valid update / Streptomyces albus DNA-DNA hybridizations, LFRFA, RAPD-PCR assays, 16S rRNA, 23S rRNA, 5S rRNA genes 23S rRNA, 5S rRNA genes, RFLPs of rRNA AJ621609 16S rRNA gene Swiderski DNA-DNA hybridizations, LFRFA, RAPD-PCR assays, 16S rRNA, 23S rRNA, 5S rRNA genes DNA-DNA hybridizations, LFRFA, RAPD-PCR assays, 16S rRNA, 23S rRNA, 5S rRNA genes DNA-DNA hybridization data and partial sequences of gyrB AB184850 16S rRNA gene DNA-DNA hybridizations, LFRFA, RAPD-PCR assays, 16S rRNA, 23S rRNA, 5S rRNA genes, RFLPs of rRNA EU790486.1 16S rRNA gene DNA-DNA hybridization data and partial sequences of gyrB DQ442528 16S rRNA gene DNA-DNA hybridization data and partial sequences of gyrB EF178671 16S rRNA gene [90] NAD Current taxonomy valid update / Streptomyces netropsis DNA-DNA hybridization, partial sequences of the gyrB gene, 16S rRNA fragment AY094370 16S rRNA gene Actinomadura yumaensis sp. nov Polycyclic ether antibiotic 16S rDNA studies on members of Arthrobacter and Micrococcus: an aid for their taxonomic restructuring Reclassification of Cellulomonas cellulans (Stackebrandt and Keddie 1986) as Cellulosimicrobium cellulans gen. nov., comb. nov A novel protein-deamidating enzyme from Chryseobacterium proteolyticum sp. nov., a newly isolated bacterium from soil The genus Escherichia Taxonomic revision of the genus Geobacillus: emendation of Geobacillus, G. stearothermophilus, G. jurassicus, G. toebii, G. thermodenitrificans and G. thermoglucosidans (nom. corrig., formerly 'thermoglucosidasius') Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb The phylogenetic significance of peptidoglycan types: Molecular analysis of the genera Microbacterium and Aureobacterium based upon sequence comparison of gyrB, rpoB, recA and ppk and 16SrRNA genes Emended descriptions of the genus Micrococcus, Micrococcus luteus (Cohn 1872) and Micrococcus lylae (Kloos et al. 1974) Transfer of Bacillus alginolyticus, Bacillus chondroitinus, Bacillus curdlanolyticus, Bacillus glucanolyticus, Bacillus kobensis, and Bacillus thiaminolyticus to the genus Paenibacillus and emended description of the genus Paenibacillus Paenibacillus lentus sp. nov., a βmannanolytic bacterium isolated from mixed soil samples in a selective enrichment using guar gum as the sole carbon source Pseudomonas classification. A new case history in the taxonomy of gram-negative bacteria Tuberibacillus calidus gen. nov., sp. nov., isolated from a compost pile and reclassification of Bacillus naganoensis Tomimura et al. 1990 as Pullulanibacillus naganoensis gen. nov., comb. nov. and Bacillus laevolacticus Andersch et al. 1994 as Sporolactobacillus laevolacticus comb Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum comb Database on potential toxigenic capacities of microorganisms used for industrial production nov Flavobacterium multivorum, a new species isolated from human clinical specimens and previously known as group IIk, biotype 2 The taxonomy of Streptomyces and related genera Taxonomic evaluation of Streptomyces albus and related species using multilocus sequence analysis and proposals to emend the description of Streptomyces albus and describe Streptomyces pathocidini sp Taxonomic re-evaluation of whorl-forming Streptomyces (formerly Streptoverticillium) species by using phenotypes, DNA-DNA hybridization and sequences of gyrB, and proposal of Streptomyces luteireticuli (ex Katoh and Arai 1957) corrig., sp. nov., nom. rev Phylogenetic analysis of the genera Streptomyces and Kitasatospora based on partial RNA polymerase betasubunit gene (rpoB) sequences Phylogenetic study of the species within the family Streptomycetaceae Comparative ribosomal protein (L11 and L30) sequence analyses of several Streptomyces spp. commonly used in genetic studies Paenibacillus macerans possesses two types of 16S rDNA copies in a genome with a length difference of twelve base pairs Taxonomy and significance of black Aspergilli Combined Molecular and Biochemical Approach Identifies Aspergillus japonicus and Aspergillus aculeatus as Two Species Phylogeny, identification and nomenclature of the genus Aspergillus The use of RFLP analysis in classification of the black Aspergilli: reinterpretation of the Aspergillus niger aggregate Phylogenetic analysis of Aspergillus species using DNA sequences from four loci The Current Taxonomic Status of Aspergillus sojae Used in Shoyu Fermentation Non-universal usage of the leucine CUG codon and the molecular phylogeny of the genus Candida Taxonomic characterization and potential biotechnological applications of Yarrowia lipolytica Database on potential toxigenic capacities of microorganisms used for industrial production isolated from meat and meat products A monograph of the Chaetomiaceae A taxonomic study on the Japanese species of Chaetomium Phylogenetic relationships of Cryphonectria and Endothia species, based on DNA sequence data and morphology A revision of the genus Sporotrichum Species-specific primers resolve members of Fusarium section Fusarium. Taxonomic status of the edible Methylotrophic yeasts near Ogataea (Hansenula) polymorpha: a proposal of Ogataea angusta comb. nov. and Candida parapolymorpha sp Taxonomy and phylogeny of the Leptographium procerum complex, including Leptographium sinense sp. nov. and Leptographium longiconidiophorum sp. nov The family structure of the Mucorales: a synoptic revision based on comprehensive multigene-genealogies Identification and nomenclature of the genus Penicillium Modern taxonomy of biotechnologically important Aspergillus and Penicillium species Purpureocillium, a new genus for the medically important Paecilomyces lilacinus Penicillium salamii, a new species occurring during seasoning of dry-cured meat Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data A molecular phylogeny-based taxonomy of the genus Rhizopus Phylogenetic analysis of the ballistoconidium-forming yeast genus Sporobolomyces based on 18S rDNA sequences. International journal of systematic and evolutionary microbiology Molecular phylogeny of Trametes and related genera based on internal transcribed spacer (ITS) and nearly complete mitochondrial small subunit ribosomal DNA (mt SSU rDNA) sequences Polyphasic taxonomy of the genus Talaromyces Accepted Trichoderma names in the year 2015 Trichoderma: systematics, the sexual state, and ecology Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes Targeting Conserved Genes in Fusarium Species β-tubulin paralogue tubC is frequently misidentified as the benA gene in Aspergillus section Nigri taxonomy: primer specificity testing and taxonomic consequences Identification of fungi of the genus Aspergillus section nigri using polyphasic taxonomy Biodiversity and ITS-RFLP characterisation of Aspergillus section Nigri isolates in grapes from four traditional grape-producing areas in Greece Comparison of 61 sequenced Escherichia coli genomes The Geobacillus Pan-Genome: Implications for the Evolution of the Genus Genomic analysis of six new Geobacillus strains reveals highly conserved carbohydrate degradation architectures and strategies Comparative Genomics of Klebsiella pneumoniae Strains with Different Antibiotic Resistance Profiles Genetic Characterization of the Klebsiella pneumoniae waa Gene Cluster, Involved in Core Lipopolysaccharide Biosynthesis Genetic diversity of capsular polysaccharide biosynthesis in Klebsiella pneumoniae clinical isolates Evolutionary conservation of essential and highly expressed genes in Pseudomonas aeruginosa Targeting Conserved Genes in Penicillium Species Genome sequencing and analysis of Aspergillus oryzae Functional analyses of Trichoderma reesei LAE1 reveal conserved and contrasting roles of this regulator. G3 (Bethesda) The application of PCR in the detection of mycotoxigenic fungi in foods Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes The phylogenetic diversity of thermophilic members of the genus Bacillus as revealed by 16S rDNA analysis The identity of Penicillium sp. 1, a major contaminant of the stone chambers in the Takamatsuzuka and Kitora Tumuli in Japan, is Penicillium paneum Cloning and analysis of Candida cylindracea lipase sequences Comparative sequence analysis of citrate synthase and 18S ribosomal DNA from a wild and mutant strains of Aspergillus niger with various fungi Phylogenetic analysis of Aspergillus section Circumdati based on sequences of the internal transcribed spacer regions and the 5.8 S rRNA gene Application of the partial 16S rDNA sequence as an index for rapid identification of species in the genus Bacillus Evaluation of the hypervariable region in the 16S rDNA sequence as an index for rapid species identification in the genus Paenibacillus Further evidence for the phylogenetic coherence of actinomycetes with group B-peptidoglycan Comparative sequence analysis of 23S rRNA from proteobacteria Emended descriptions of Geobacillus thermoleovorans and Geobacillus thermocatenulatus Sequence heterogeneities among 16S ribosomal RNA sequences, and their effect on phylogenetic analyses at the species level Phylogenetic analysis of the genera Cellulomonas, Promicromonospora, and Jonesia and proposal to exclude the genus Jonesia from the family Cellulomonadaceae Gene cloning, expression, and biochemical characterization of an alkali-tolerant beta-mannanase from Humicola insolens Y1 Taxonomy of Penicillium citrinum and related species Recombination Blurs Phylogenetic Groups Routine Assignment in Escherichia coli: Setting the Record Straight Taxonomic revision of the cellulose-degrading fungus Acremonium cellulolyticus nomen nudum to Talaromyces based on phylogenetic analysis Acaricomes phytoseiuli gen. nov. sp. nov., isolated from the predatory mite Phytoseiulus persimilis Resequencing of Sphingobacterium multivorum Phylogenic analysis of the genus Streptomyces Endophytic actinomyces isolated from Ephedra glaoca Classification of novel soil streptomycetes as Streptomyces aureus sp. nov., Streptomyces laceyi sp. nov. and Streptomyces sanglieri sp Streptomyces violaceoruber clade Cloning and characterization of the acting gene from Yarrowia lipolytica Bowman BH and Nuss DL Phenotypic changes associated with hypovirus RNA transfection of plant pathogenic fungi phylogenetically related to Cryphonectria parasitica Communities of wood-inhabiting fungi in mountain pine (Pinus mugo Turra) Phylogenetic relationships among Mucoraceae, Choanephoraceae and Gilbertellaceae based on rDNA and glyceraldehyde-3-phosphate dehydrogenase sequences Molecular evidence that the asexual industrial fungus Trichoderma reesei is a clonal derivative of the ascomycete Hypocrea jecorina Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species Biological management of aflatoxigenic fungi and aflatoxin in field grown groundnuts Isolation and identification of a lignin degrading fungi Investigations of Biodeterioration by Fungi in Historic Wooden Churches of Chiloe A reassessment of the Talaromyces funiculosus aggregate, introducing the new species Talaromyces versatilis Polyphyletic origins of species of the anamorphic genus Geosmithia and the relationships of the cleistothecial genera: Evidence from 18S, 5S and 28S rDNA sequence analyses Mycologia Pathogenic fungi isolated from tobacco seed Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data Molecular studies on Rhizopus (I): Relationships among species based on ITS rDNA and pyrG gene Molecular characterization of a seed transmitted clavicipitaceous fungus occurring on dicotyledoneous plants Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family Isolation and Screening of Cellulolytic fungal species from soil Isolation and Molecular Characterization of Cr Resistant Fungi Having Competence to Degrade Anthracene From Industrial Effluent of South Gujarat Cohn 32015 18S ribosomal RNA gene, partial sequence Screening and Identification of Sea Fan-Derived Fungi that Produce Antimicrobial Substances A comparative study between Malaysian and Japanese actinomycets Cloning and nucleotide sequences of two lipase genes from Candida cylindracea Evidence that a secondary metabolic biosynthetic gene cluster has grown by gene relocation during evolution of the filamentous fungus Fusarium Development of an oligonucleotide probe for Aureobasidium pullulans based on the small-subunit rRNA gene Thermoactive extracellular proteases of Geobacillus caldoproteolyticus, sp. nov., from sewage sludge Application of rpoB sequence similarity analysis, REP-PCR and BOX-PCR for the differentiation of species within the genus Geobacillus Complete nucleotide sequence of a 16S ribosomal RNA gene from Pseudomonas aeruginosa Uncommonly isolated clinical Pseudomonas: identification and phylogenetic assignation Rapid Detection and Identification of Mucormycetes from Culture and Tissue Samples by Use of High-Resolution Melt Analysis We thank the following EFSA satff: Jaime Aguilera, Margarita Aguilera-Gómez, Jane Richardson, Mario Monguidi and Davide Gibin for their valuable help and collaboration throughout the project. We also would like to thank the members of AINIA: Sonia Porta, Lidia Tomás, Joaquin Espí and Juan Antonio Nieto for providing expertise in biotechnology and molecular biology and contributing with their efforts to achieve the goals of this project, and Violeta Gómez from the University of Navarra for her collaboration in the final editing of the Appendix J. Finally, we would like to thank Maria Frontera from AINIA for revising the quality of the work produced and final report. Database on potential toxigenic capacities of microorganisms used for industrial production Appendix K -Taxonomy references